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  Abstract 
Deciphering the mechanism and function of stage-specific protein association with 
the membrane cytoskeleton of Toxoplasma gondii  
Author: Rashmi Dubey 
Advisor: Prof. Marc-Jan Gubbels 
Apicomplexan parasites like Toxoplasma gondii have a complex life cycle comprising of 
transitions between different hosts, different organ systems and between the extracellular 
and intracellular milieu. The parasite must thus adjust itself and its cellular processes in 
accordance with its environment. In this dissertation, I have focused on such stage 
specific behaviors of three distinct intermediate filament-like proteins as well as a 
glycolytic enzyme, glyceraldehyde-3-phosphate dehydrogenase 1 (GAPDH1). These 
proteins relocate from the cytosol to the unique cortical membrane skeleton of non-
dividing parasites. The intermediate filament-like proteins IMC7, 12 and 14, localize 
exclusively to the mature cytoskeleton. One model of function was that these proteins 
differentially stabilized mother and budding daughter cytoskeletons in the division 
process, but we ruled out this role for the individual proteins, as they are not essential for 
the lytic cycle of the parasite. However, we determined that IMC7 and IMC14 are 
contributing to the maintenance of rigidity of the cytoskeleton under osmotic stress 
conditions in extracellular parasites. In addition, IMC14 is critical in cell cycle 
progression as its depletion results in the formation of multiple daughters per division 
round. When the parasite egresses from the host cell, glycolytic enzyme GAPDH1 
translocates to the cortex. The functional role of GAPDH1 in the parasite and the 
mechanism of its cortical translocation are deciphered based on the 2.25Å resolution 
	  crystal structure of the GAPDH1 holoenzyme in a quaternary complex. These studies 
identified that GAPDH1’s enzymatic function is essential for intracellular replication but 
we confirmed the previous reports that glycolysis is not strictly essential in presence of 
excess L-glutamine. We identify, for the first time, S-loop phosphorylation as a novel, 
critical regulator of enzymatic activity that is consistent with the notion that the S-loop is 
critical for cofactor binding, allosteric activation and oligomerization. We show that 
neither enzymatic activity nor phosphorylation state correlate with the ability to 
translocate to the cortex. However, we demonstrate that association of GAPDH1 with the 
cortex is mediated by Cysteine 3 in the N-terminus, likely by palmitoylation. Overall, 
glycolysis and cortical translocation are functionally decoupled by post-translational 
modifications. Collectively, the discoveries made in this dissertation reveal 
unprecedented detail in mechanism and function of cortical protein translocation and 
thereby identifying new drug targets.  
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CHAPTER 1: INTRODUCTION 
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1.1. Introduction  
Toxoplasma gondii is a ubiquitous apicomplexan capable of infecting any nucleated cell 
within a wide variety of warm-blooded vertebrates including human (Frenkel, 1973; 
Huynh et al., 2003). The phylum Apicomplexa consists of approximately 5000 species 
(Levine, 1988) which are nearly all obligate intracellular parasites and are defined by the 
presence of a complex apical cytoskeleton and secretory organelles (Hu et al., 2006). 
Toxoplasma is distinct from nearly all other members owing to the exceptionally wide 
range of animals that serve as host for its intermediate life cycle (Frenkel et al., 1970). 
Generally regarded as an opportunistic pathogen, T. gondii is responsible for the 
development of toxoplasmosis-associated encephalitis and congenital toxoplasmosis in 
humans (Luft and Remington, 1992; Montoya and Liesenfeld, 2004).  
Other pathogens in this phylum of medical and economic importance affect 
humans and livestock. Plasmodium is a human pathogen, the causative agent of malaria, 
and results in the death of half a million individuals annually (Starkl Renar et al., 2016). 
Cryptosporidium species and Cyclospora cayetanesis cause severe gastrointestinal 
enteritis specifically diarrhea (Francia and Striepen, 2014; Mansfield and Gajadhar, 
2004). Neospora caninum is a livestock pathogen causing clinical disease like 
neosporosis associated with abortion in cattle and causes significant economic loss to 
both dairy and beef industries (Larson et al., 2004). Babesia and Theileria species 
transmitted by ticks infect wild and domestic animals including dogs, cattle, goats and 
sheep (Bishop et al., 2004; Schnittger et al., 2012), and infection of poultry by Eimeria 
species results in coccidiosis, causing severe economic loss worldwide (McDonald and 
Shirley, 2009).  Since Apicomplexa are pathogens, the development of new drugs and 
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drug target candidates is a mainstay driver for studying these parasites and it is inevitable 
that there will be a big gain by understanding the parasite biology and underlying 
molecular process.  
 
1.2. Epidemiology and pathogenesis 
Infections by the protozoan parasite Toxoplasma gondii are widely prevalent worldwide 
in both animals and human. Currently, one third of the world’s population is infected 
(Montoya and Liesenfeld, 2004) and an estimated 1.1 million persons in the United States 
are infected each year (Jones and Holland, 2010). It is the second leading cause of death 
attributable to foodborne illness and leading contributor to loss of quality adjusted life 
years (Jones et al., 2014). The parasite has a typical heteroxenous life cycle alternating 
between sexual replication in felids and asexual replication in a wide range of warm-
blooded animals that serve as intermediate hosts (Frenkel et al., 1970). Infection occurs 
by food-borne transmission when the host ingests undercooked or raw meat containing 
the parasite in tissue cysts or through ingestion of either soil, food or water contaminated 
by cat feces harboring oocysts (Jones and Holland, 2010). Tachyzoites are the rapidly 
growing stage formed by asexual reproduction in all the intermediate hosts causing acute 
infections. Most acute infections pass with mild or no symptoms, but severe disease 
occurs in immuno-compromised patients (Barsoum, 2004; Luft and Remington, 1992; 
Sahasrabudhe et al., 2003). In healthy individuals, the infection is usually asymptomatic 
and results in the formation of dormant encysted bradyzoites that remain in the brain and 
muscle tissues for life and thus cause chronic infection. Reactivation of such latent 
infection occurs in immunocompromised HIV/AIDS patients, immuno-suppressed organ 
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transplant-recipients and patients undergoing anti cancer treatment, affecting the central 
nervous system, leading to toxoplasmotic encephalitis (Luft and Remington, 1992). 
Primary infection in naïve pregnant women can lead to transplacental transmission of the 
parasite causing congenital toxoplasmosis, which may result in abortion, 
retinochoroiditis, and mental retardation (Wong and Remington, 1994). The current drug 
therapy is a combination of pyrimethamine and sulfadiazine, which targets the folate 
pathway and effectively kills the tachyzoite stage; such treatments do not remove the 
chronic infection and as a result long-term therapy is needed in immunocompromised 
patients (Rajapakse et al., 2013). These drugs have numerous side effects like nausea, 
vomiting, diarrhea, fever, rash, bone marrow suppression, neuropathy and hematuria 
(Kaye, 2011). The toxic side effects combined with their inability to eliminate infection 
highlights the need for safer and more effective treatments.  
 
1.3. Lytic cycle of the parasite 
The pathogenesis of this parasite absolutely depends on its ability to reiterate its lytic 
cycle, which is composed of invasion, intracellular replication and egress from the host 
cell (Figure 1.1.). Invasion is a multi-step process consisting of recognition, attachment 
and active penetration of a host cell. The parasite attaches to the potential host through its 
surface protein coat SAGs and releases contents of its specialized secretory organelles 
microneme and rhoptry, to form a tighter interaction called the moving junction (MJ) 
(Kafsack et al., 2007). The MJ is a ring like structure formed on the interface between the 
host cell and parasite at the entry point into the host cell. It is a collaboration of rhoptry 
neck proteins (RONs) assembled in the host cell plasma membrane and microneme 
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protein apical membrane antigen 1 (AMA1) anchored in the parasite (Alexander et al., 
2005). The active penetration of the host cells by the parasite results in the formation of 
specialized, non-fusogenic compartment termed the parasitophorous vacuole (PV) within 
which the parasites reside and replicate (Joiner and Dubremetz, 1993; Soldati et al., 
2001). A myosin motor complex termed the glideosome powers parasite propulsion into 
the host cell and is required for efficient invasion. It is not completely understood if 
motility is a strict requirement of invasion as in absence of many glideosome components 
some parasites are able to invade and develop normally (Blader et al., 2015). Recent 
reports claim that host cell membranes are actively involved in the invasion process and 
specifically host cell actin is critical for parasite internalization (Bichet et al., 2016). 
Following successful invasion, parasites replicate by internal budding and continue 
multiplying in the PV until it fills the host cell cytoplasm. The parasite initiates to egress 
through different mechanisms like increased concentration of abscisic acid, decreased pH 
and increased secretion of nucleotide triphosphate-degrading enzymes (NTPases).  Upon 
egress from the host cell, the tachyzoites demonstrate actinomyosin based gliding 
motility to search for the nearby host. Thus, gliding motility, invasion and egress are 
vastly interconnected though the molecular mechanisms governing these processes are 
highly diverse. 
 Division of the parasite occurs via internal budding or endodyogeny where two 
daughter parasites are formed within a mother (Sheffield and Melton, 1968). The 
initiation of cell division occurs by the duplication of the Golgi apparatus late in G1 (Hu 
et al., 2002) followed by the replication of the centrosome early in S phase (Hartmann et 
al., 2006; Hu et al., 2002; Nishi et al., 2008). The centrosome plays a pivotal role in 
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coordinating the mitotic and cytokinetic events (Chen and Gubbels, 2013). The 
centrosome is comprised of an inner and outer core, which involves two functionally 
distinct regions separately regulating mitosis and cell division, respectively (Suvorova et 
al., 2015). The outer core provides spatial cues for daughter cytoskeleton assembly driven 
by recruitment and assembly of the cortical cytoskeletal components forming the new 
daughter scaffold. Karyokinesis and cytokinesis progress simultaneously as the 
cytoskeleton grows providing structural integrity (Mann and Beckers, 2001; Striepen et 
al., 2007). In this process it engulfs the divided Golgi (Nishi et al., 2008), then the 
apicoplast (Striepen et al., 2000), the nucleus and endoplasmic reticulum (Hager et al., 
1999; Hu et al., 2002) and finally the mitochondrion (Nishi et al., 2008). The apical 
secretory organelles (micronemes and rhoptries) are formed de novo, within the 
developing parasite (Nishi et al., 2008; Sheffield and Melton, 1968). Division is 
completed by the breakdown of the mother’s cytoskeleton whereas the plasma membrane 
is recycled onto the daughter parasites (Morrissette and Sibley, 2002). The 
unencapsulated material of the mother parasite is degraded away in a residual body 
(Sheffield and Melton, 1968). 
 Upon completion of replication, the egressing parasite becomes motile to search 
for new host cells to continue to the lytic cycle (Sibley, 2004). The extracellular parasites 
are in a biologically distinct state from the intracellular form; they do not divide, are 
highly motile, and secrete the contents of their microneme organelles (Blader et al., 
2015). The switch between the intracellular and extracellular states is accompanied by 
dramatic changes in gene expression (Gaji et al., 2011; Lescault et al., 2010), mRNA 
availability for translation (Lirussi and Matrajt, 2011) and translocation of glycolytic 
7	  	  
enzymes as described in detail in section 1.5 (Pomel et al., 2008). The activation toward 
the extracellular stage is in a way first step of host cell invasion (Hoff and Carruthers, 
2002).  
 
1.4. Cytoskeleton of Toxoplasma and the intermediate-filament like proteins 
The tachyzoite is crescent shaped with a pellicle consisting of an outer plasma membrane, 
an inner membrane complex (IMC) and a microtubule structure (Figure 1.2.) (Foussard et 
al., 1990). The cytoskeleton provides mechanical strength to the parasite to maintain its 
structural integrity and in addition is the main driver of cell division (Mann and Beckers, 
2001). The IMC is a double membrane system composed of a patchwork of flattened 
membranous sacs called alveoli which are rectangular and arranged in three rows 
encircling the entire parasite with a single cone shaped vesicle capping the apical end 
(Dubremetz and Elsner, 1979; Porchet and Torpier, 1977). There are 22 subpellicular 
microtubules that originate from the apical polar ring and extend two-third the length of 
the parasite in spiraling fashion (Nichols and Chiappino, 1987). The subpellicular 
microtubules are associated with the IMC by microtubule-associated proteins, which are 
anchored to inner membranous particles (IMPs) (Morrissette et al., 1997; Morrissette and 
Sibley, 2002). These IMPs are also present on the inner and middle faces of the IMCs in 
double and single rows with 32 nm periodicity extending along the entire length of the 
parasite (Dubremetz and Torpier, 1978; Morrissette et al., 1997). The IMC also runs 
along the entire length of the parasite with gaps at the apical and posterior end. The 
opening at the apical end allows for the extension of the conoid during invasion while the 
posterior end is occupied by the basal cup whose functions are still unclear (Del Carmen 
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et al., 2009; Mann and Beckers, 2001). MORN1 a highly conserved apicomplexan 
protein localizes to the apical and posterior end of the parasite and to the centrocone, a 
specialized nuclear structure that organizes the mitotic spindle (Gubbels et al., 2006). 
 The parasite has an atypical actin cytoskeleton, comprised mainly of the globular 
form and transient formation of short actin filaments occurs during host cell invasion and 
gliding motility of the parasite (Dobrowolski and Sibley, 1996). Filamentous actin 
transiently forms to harbor the motility apparatus called glideosome, which contains 
Myosin A, Myosin Light Chain 1 and the membrane anchoring protein GAP45 and 
GAP50 (Keeley and Soldati, 2004). The parasite is able to invade successfully even in the 
absence of core components of the invasion machinery like actin, MyoA, AMA1, MIC2 
(Andenmatten et al., 2013; Bargieri et al., 2013; Egarter et al., 2014) likely due to 
plasticity between the motor proteins like MyoC and MyoA (Frenal et al., 2014b) or the 
contribution of host cell membrane to invasion (Bichet et al., 2016). However, actin is 
essential for apicoplast replication (Andenmatten et al., 2013) and appears to be involved 
in the step upstream of formation of MJ during parasite invasion (Egarter et al., 2014), 
but parasites are able to complete cell division indicating actin is not required for 
contractile ring constriction. 
 The cytoskeletal network is a complex structure composed of 8-10 nm-interwoven 
intermediate-filaments located on the cytoplasmic face of the IMC. In the membrane sac 
are the IMC subcompartment proteins namely ISP1, ISP2, ISP3 and ISP4 localized to the 
distinct subcompartment of the IMC (Beck et al., 2010). Recently, other novel IMC 
proteins localizing to the specific IMC compartment or alveolar sutures have also been 
discovered (Chen et al., 2015). Specifically, the intermediate filament-like (IF-like) 
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proteins contain a series of conserved repeats called alveolins, which contains valine and 
proline-rich domains (Gould et al., 2008). These domains are composed of ‘EKIVEVP’, 
‘EVVR’ or ‘VPV’ sub repeats (Gould et al., 2008) and T.gondii genome has 14 alveolin 
domain containing genes (Anderson-White et al., 2011). The assembly process of the 
IMC proteins and other cytoskeleton proteins during budding process has been 
established in detail (Anderson-White et al., 2012). Different groups are defined within 
the alveolin IMC protein family: a group localizing exclusively to the basal complex 
(IMC5, 8, 9, and 13); IMC 15 colocalizing with the centrosome and early daughter buds; 
a group at the cortex of the mature mother and daughter parasites (IMC1, 3, 4, 5, 6, and 
10), and finally a group localizing to the mature cytoskeleton (IMC7, 12, and 14) 
(Anderson-White et al., 2011). Thus, it is hypothesized that these IMC proteins fulfill 
different functions in the parasite during cytoskeletal assembly, maturation, maintenance 
and/or disassembly (Anderson-White et al., 2011). 
 
1.5. GAPDH: more than housekeeping 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a key enzyme of glycolysis and 
catalyzes the oxidative phosphorylation of glyceraldehyde 3-phophate to D-glycerate 1,3-
bisphosphate in presence of NAD+ and inorganic phosphate during glycolysis. GAPDH 
has been studied for its pivotal role in glycolysis and is a common housekeeping protein. 
For its abundant and constitutive expression, GAPDH is used as an internal control for 
analysis and expression of other genes and proteins. Besides its glycolytic function, 
GAPDH is an impressive multifunctional protein with diverse activities and distinct sub-
cellular localization (Sirover, 1999, 2011). These varied functions include membrane 
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fusion and transport (Glaser and Gross, 1995; Tristan et al., 2011), cytoskeletal dynamics 
(Kumagai and Sakai, 1983), post-transcriptional gene regulation (Bonafe et al., 2005; 
Sirover, 1999), chromatin structure (Demarse et al., 2009; Sundararaj et al., 2004), 
maintenance of DNA integrity (Azam et al., 2008) and the facilitation of actin 
polymerization and microtubule bundling (Kumagai and Sakai, 1983; Reiss et al., 1996). 
The diverse functions are likely regulated by post-translational modifications next to 
changes in sub-cellular localization and oligomerization (Tristan et al., 2011). For 
example, the association of GAPDH with vesicular tubular clusters, which function as 
transport complexes, carrying cargo between endoplasmic reticulum and the Golgi 
apparatus, is mediated by tyrosine phosphorylation of GAPDH by an atypical protein 
kinase. Phosphorylated GADPH is recruited to Rab2 and thereby promotes the interaction 
between microtubules and motor proteins with Rab2-mediated vesicles. Notably, most of 
these additional roles of GAPDH are independent of its glycolytic function (Robien et al., 
2006; Tisdale, 2001, 2002; Tisdale and Artalejo, 2006; Tisdale et al., 2004).   
In Toxoplasma, all glycolytic enzymes except hexokinase and glucose-6-
phosphate isomerase occur in duplicate in the genome (Fleige T, 2007). The complete set 
of the ten enzymes that form the glycolytic pathway is targeted to the cytosol while the 
other isoforms localize to the apicoplast or nucleus in case of enolase (Fleige T, 2007). It 
was further discovered that the glycolytic enzymes like GAPDH1, aldolase and LDH1 
are translocated from the cytoplasm to the pellicle of the parasite upon egress from the 
host cell (Pomel et al., 2008). These enzymes remain pellicle-associated throughout the 
extracellular phase and during invasion of the host cell (Pomel et al., 2008). The enzyme 
translocation is triggered by the changes in extracellular potassium and intracellular 
11	  	  
calcium ion concentrations during egress from host cell. Upon successful invasion, the 
localization of GAPDH1 reverts back to the cytoplasm (Pomel et al., 2008). Glycolytic 
enzymes become peripheral in other organisms as well. In freshly isolated human 
erythrocytes, many glycolytic enzymes are intimately associated to the inner face of the 
plasma membrane, but are cytoplasmic in deoxygenated cells (Campanella et al., 2005b). 
It is hypothesized that this association is related to the generation of highly 
compartmentalized pool of ATP for the efficient consumption by ion and nutrient 
transporters. Similarly, the close association of the glycolytic enzymes to the pellicle of 
Toxoplasma is related to the highly localized production of ATP in the extracellular 
parasites. This is hypothesized to occur for improved delivery of ATP by the active 
transporter mechanism in the parasite plasma membrane and to the motile apparatus 
situated in the space between plasma membrane and IMC (Pomel et al., 2008; Sirover, 
2011).  
 The crystal structure of GAPDH has been established for numerous species and in 
general the enzyme crystallizes as a tetramer with dihedral symmetry. The N-terminus 
includes NAD+ binding domain also called the Rossman domain and the C terminus 
contains catalytic domain (Akinyi et al., 2008). A loop separating the NAD+ binding 
cavities of adjacent subunits, called the S-loop, is in close proximity to the catalytic 
domain. It regulates the activity of the enzyme by creating a wide pocket to centrally 
position the nicotinamide ring into the active site pocket. The key differences of other 
GAPDH like Leishmania and Trypanosma has been extensively explored in relation to 
the human GAPDH as a putative drug target (Lakhdar-Ghazal et al., 2002; Opperdoes 
and Michels, 2001). In trypanosomes, the binding site for the adenosine portion of NAD+ 
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in GAPDH has a hydrophobic cleft and adenosine derivatives competing with this 
binding site have been developed. These inhibitors can stunt the growth of the parasite in 
culture at low concentration and future research to optimize the affinity and selectivity of 
these inhibitors is required to make them suitable for toxicity and in vivo activity 
(Lakhdar-Ghazal et al., 2002; Verlinde et al., 2001). In Leishmania the glycolytic 
enzymes aldolase and enolase have been reported as possible vaccine candidate against 
visceral leishamaniasis (Gupta et al., 2014).   
 
1.6. Open questions and thesis synopsis 
The pathogenesis of Toxoplasma is closely linked to rapid replication rounds, which rely 
on the proper formation of the cytoskeleton. The spatio-temporal behavior of the proteins 
associated with the IMC namely IMC7, IMC12 and IMC14 are defined and they localize 
to the mature cytoskeleton, upon the completion of budding. It has been hypothesized 
that these IMCs mark the newly formed daughter cells from the degrading mother and 
thereby are a key to successful internal budding (Anderson-White et al., 2011). In 
addition to IMC proteins translocating to the pellicle of non-dividing G1 cell stage 
tachyzoites, the glycolytic enzymes make a similar translocation but upon parasite egress, 
basically in an arrested G0 state of the cell cycle (Figure 1.3.). Neither the mechanism nor 
the significance of these translocations to the cortex is currently well understood. A better 
understanding of the unique features of these translocation events might provide insights 
for the development of parasite specific drugs. This dissertation sets out to identify the 
mechanism and potential shared mechanisms in the regulation of translocation, as well as 
to unravel the functions of these translocations.  
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Figure 1.1. Lytic cycle of the parasite 
 
The schematic of simplified version of lytic cycle showing invasion, replication and 
egress of the parasite from the host cell. Reprinted material does not require permission 
from Annual Reviews: Annual Reviews of  Microbiology (Blader et al., 2015).  
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Figure 1.1. Lytic cycle of the parasite 
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Figure 1.2. Schematic representation of Toxoplasma cytoskeleton 
 
Three-part structure of cytoskeleton composed of microtubules on the inner side covered 
by the IMC meshwork of protein and the alveolar vesicle below the plasma membrane. 
Reprinted with minor adaptations by permission granted from the Elsevier publisher: 
International Review of Cell and Molecular Biology (Anderson-White et al., 2012) .  
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Figure 1.2. Schematic representation of Toxoplasma cytoskeleton 
  
 
 
  
17	  	  
Figure 1.3. Biological stages of parasite: Extracellular and intracellular state.  
 
Glycolytic enzymes like GAPDH1 and cytoskeletal protein like IMC12 is localized to the 
cortex in the extracellular state of the parasite. The parasite replication and its cell cycle 
stages are highlighted in the intracellular state. During G1 the centrosome is intact and it 
duplicates early in S phase to provide cue for appearance of cytoskeleton elements. The 
daughter buds begin to form as the cytoskeleton grows and fully formed daughter 
parasites appear (S-M phase) engulfing the mother in a short cytokinesis phase (C-phase). 
Nucleus: light blue; MORN1: green; IMC: dark blue; tubulin and centrosome: red. 
Reprinted with minor adaptations by permission granted from the publisher Company of 
Biologists Ltd: Journal of Cell Science  (Gubbels et al., 2006).  
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Figure 1.3. Biological stages of parasite: Extracellular and intracellular state 
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CHAPTER 2: FUNCTIONAL ANALYSIS OF THE GROUP OF INTERMEDIATE 
FILAMENT-LIKE PROTEINS ASSOCIATING WITH THE CYTOSKELETON 
AFTER CELL DIVISION IN TOXOPLASMA 
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2.1. Introduction 
In Toxoplasma gondii, the association of plasma membrane with an IMC (composed of 
the flattened alveolar sacs) coupled to a supporting cytoskeletal network builds the 
cortical membrane skeleton (Mann and Beckers, 2001). The IMC plays a critical role in 
parasite replication (Radke et al., 2001), motility and invasion (Dobrowolski and Sibley, 
1997; Meissner et al., 2002). A fine 8-10 nm meshwork of intermediate filament-like 
proteins arranged below the alveoli are called IMC proteins. A family of 14 IMC proteins 
shares alveolin domains composed of valine and proline-rich residues (Anderson-White 
et al., 2011) (Figure 2.1. a). The members of this family are sequentially assembled into 
the cytoskeleton of budding daughter cells and mark distinct developmental steps in the 
budding process (Figure 2.1. b) (Anderson-White et al., 2011). A subset of these proteins 
namely, IMC7, IMC12 and IMC14 only associate with the mature cytoskeleton in the G1 
stage of the cell cycle, which makes this group a unique subfamily in the alveolin repeat 
family (Anderson-White et al., 2011) (Figure 2.1. c). Specifically, IMC7 appears after the 
association of IMC14 in the early G1 stage (Szatanek et al., 2012) (Figure 2.1. c). None 
of these proteins have been functionally characterized. Here we aim to decipher the 
functional significance of these three proteins in the lytic cycle of the parasite.  
 Two hypotheses regarding the function of this group of non-division IMC 
proteins are explored here. Firstly, this group of IMC proteins may serve as a mark to 
differentiate mother and daughter cytoskeleton. This is important during the final phases 
of cell division when the mother’s cytoskeleton is being degraded whereas the daughters 
mature and emerge (Anderson-White et al., 2011). Alternatively, these IMCs may be 
involved in maintaining and strengthening the cortical cytoskeleton of the parasite 
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(Anderson-White et al., 2011) to allow the parasite to survive stresses in the extracellular 
environment and/or during host cell invasion. We demonstrate here that individual genes 
are not essential to the parasite per se, but that IMC7 and IMC14 are needed to withstand 
osmotic stress. Although a role for IMC12 could not be established in our experiments, 
we discovered that IMC14 is also required to produce two rather than more daughters per 
division round. This function in division is unexpected and ties structural elements to a 
role in the cell development cycle.   
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2.2. Results  
 
2.2.1. IMC7, 12 and 14 associates to the cortex in late G1 stage  
Although it has been shown that IMC7 appears at the cortex after the association of 
IMC14 in the early G1 stage using a temperature sensitive mutant arresting in early G1 
(Figure 2.2. a) (Szatanek et al., 2012), this timing has not been determined for IMC12. In 
addition, it is currently unknown whether upon progression of G1 toward S/M phase all 
these IMC proteins translocate in all parasites, a requirement if these proteins were to 
function to differentially mark mother and daughter cytoskeletons. To answer these 
questions, we used exogenous N-terminal and C-terminal fusions of IMC7, 12 and 14 
with auto fluorescent YFP protein (Anderson-White et al., 2011). Consistent with the 
previous report, IMC12 was expressed under a constitutive tubulin promoter but native 
promoters drove IMC7 and IMC14 to ensure proper spatiotemporal dynamics (Anderson-
White et al., 2011).  
  Like described in previous work, the cortical transition of IMC7 and IMC14 was 
studied in a temperature sensitive mutant (named FV-P6) of the Cactin gene that arrests 
in mid G1 (Szatanek et al., 2012). We also subject IMC12 to this analysis (Figure 2.2. c-
e). This showed that IMC7 and 12 display similar translocation dynamics, with about 
60% of the parasites displaying cortical localization of the protein in both non-
synchronized, random cycling parasites (35°C) as well as mid G1 arrested (40°C) 
parasites. Consistent with the mRNA expression profile maximizing in early G1, the 
IMC14 translocation goes from just over 60% to nearly 100% upon G1 arrest.  
 To understand the localization of these IMC proteins upon progression of G1, we 
treated the parasite lines expressing IMC7, 12 or 14 fused to YFP with 3-methyladenine 
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(3-MA) to arrest the parasites in late G1 stage and again scored for cortical vs. 
cytoplasmic localization (Figure 2.2. b) (Wang et al., 2010). Over 90% of the vacuoles 
contained parasites with IMC7, 12 and 14 at the cortex (Figure 2.2. c-e). Overall, these 
data fit with the mRNA expression profile for these IMC proteins. In addition, the near 
uniform translocation at the end of G1 is consistent with a putative role for these IMC 
proteins in marking the mature mother for degradation, although a role in strengthening 
the cortex for stress resistance in extracellular parasites cannot be excluded based on 
these data.   
 
2.2.2. IMC12 transitions to the cortex in extracellular parasites 
To understand if IMC7, 12 and 14 function in maintaining the rigidity of the cytoskeleton 
of parasites outside the PV, we scored the cortical localization of parasite lines expressing 
YFP fused to IMC7, 12 or 14 in the extracellular stage. We mechanically released 
asynchronously dividing parasites and determined the percentage of vacuoles harboring 
parasites with cortical YFP signal after increasing time points following release from the 
host cell. In an asynchronous population at t = 0 hrs, roughly 40% of vacuoles harbor 
parasites displaying all three IMCs in the cortex (Figure 2.3.). This percentage only 
slightly fluctuates for IMC7 and IMC14 over a 24 hrs period; however, the cortical 
IMC12 population significantly increases from 32% to 69% in 24 hrs. These data suggest 
that IMC7 and 14 are unlikely to function in resisting extracellular stresses, but the 
doubling of IMC12 over the 24 hr window is consistent with such function. 
 
2.2.3. Loss of IMC7 shows reduced ability to resist osmotic shock 
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To dissect the function of IMC7 in the lytic cycle of the parasite, we created a cKD line 
by replacing the endogenous promoter of IMC7 with anhydrous tetracycline (ATc) 
regulatable minimal TetO7Sag4 promoter (Figure 2.3. a). After the verification of the 
integration of the regulatable promoter and absence of endogenous pimc7 promoter 
(Figure 2.3. b), we monitored the downregulation of the IMC7 protein by IFA (Figure 
2.3. c) and western blot (Figure 2.3. d). The IMC7 protein was barely detectable after 24 
hrs of ATc treatment. Plaque assays show neither a reduction in number nor area of 
plaques as compared to the parental line (Figure 2.5. a) indicating no evident loss in 
parasite viability. This result indicates that IMC7 is not required to complete the lytic 
cycle in vitro. Since plaque assays only measure overall fitness, more subtle defects can 
be observed by IFA for division markers but these IFA assays identified no division 
defects (data not shown). Additionally, to test if IMC7 is involved in maintaining the 
rigidity of the mature parasites in extracellular milieu we asked whether extracellular 
IMC7 cKD parasites were able to withstand different osmotic stress conditions (Harding 
et al., 2016). We analyzed parasite integrity through the ability of propidium iodide (PI) 
to associate with the DNA of ruptured parasites by flow cytometry. To test the assay the 
parental line was treated with a low concentration of saponin, which is known to create 
pores in the membrane. We used SAG1 conjugated with Alexa 488 to stain the parasite 
surface and distinguish the parasites from debris in the assay. We observed that 64% of 
the parasites were disrupted by saponin treatment indicating that the assay works (Figure 
2.5. b).  Hypotonic stress conditions were induced by exposure to 0.5X and 0.25X of 
normal salt concentration (HBBSs diluted with water) and hypertonic conditions were 
induced by exposure to 1 M sorbitol. IMC7 depleted parasites were two-fold less resistant 
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to hypotonic conditions than WT (wild type) parasites (Figure 2.5. b), though withstood 
the hypertonic condition quite well. These results indicate that IMC7 is involved in 
maintaining rigidity of extracellular parasites.   
 
2.2.4. IMC12 is not essential for the lytic cycle  
To assess the function of IMC12 we created a dKO line of IMC12 using double 
homologous recombination aided by the CRISPR technology (Figure 2.6. a). The 
genotype of the IMC12 dKO line was validated by diagnostic PCR reactions (Figure 2.6. 
b). Assessment of the viability by plaque assay showed no visible defect compared to the 
parental line (Figure 2.6. c). Evaluation of parasite division by immunofluorescence 
assays showed normal, synchronously dividing parasites by endodyogeny (results not 
shown). Since we observed an increase in IMC12 cortical transition in extracellular 
parasites we hypothesized a role in stress resistance. However, neither hyper- nor hypo-
osmotic stresses results in parasite permeabilization over rates observed for the WT 
control (Figure 2.6. d). Taken together, IMC12 is not essential for completion of the lytic 
cycle and acts neither on the progression of endodyogeny nor on resistance of 
extracellular stress.  
 
2.2.5. IMC14 is required for maintaining synchronous budding and cell rigidity  
To decipher the role of IMC14, we created a dKO line by double homologous 
recombination using a CRISPR mediated approach (Figure 2.7. a). The successful 
replacement of the IMC14 locus with the DHFR selectable marker indicated that IMC14 
is not essential for the parasite (Figure 2.7. b). This result was confirmed by testing the 
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fitness of the IMC14 dKO line by plaque assay where we did not detect a difference in 
the number or size of plaques when compared to the parental line (Figure 2.8. a). 
However, upon examination of the dKO parasites by immunofluorescence using the 
division markers IMC3 to mark the cytoskeleton and centrin to label the centrosomes, we 
observed a loss in synchronous budding of the parasites in nearly 20% of the population 
compared to only 3.8% for the WT control (Figure 2.8. b, c). Furthermore, under 
hyperosmotic conditions we observed a two-fold increase in the percentage of 
permeabilized parasites in absence of IMC14 compared to WT control (Figure 2.8. d). 
Additionally, in the hypertonic conditions there is about four-fold increase in the 
percentage of permeabilized parasites indicating the essentiality of the IMC14 in 
maintaining membrane rigidity upon osmotic stress. These data suggest a dual role for 
IMC14 in coordinating the transition of G1 to S/M and cytokinesis phases of the cell 
cycle in Toxoplasma as well as in maintaining parasite integrity under stress conditions.  
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2.3. Discussion 
Our complete analysis of cortical localization of the three IMC proteins shows that 
IMC14 transitions before IMC7 and 12 to the cortex during G1, but that transition is 
completed to almost 90% of the parasites by the end of G1. These data thus clearly 
demonstrate that IMC7, 12, and 14 all translocate before entering S-phase and thereby 
distinctly mark the mother cytoskeleton from newly forming daughters. In that light, it 
was surprising to find that in our analysis of the knock-down and knock-out lines none of 
these three IMC proteins appear to interfere with mother cell turnover. However, at this 
point we cannot exclude functional redundancy among these three IMC proteins. 
Toxoplasma has an armor of flattened vesicles along with subpellicular 
microtubules and intramembranous particles (Morrissette et al., 1997) which are further 
decorated with microtubule coating proteins (Liu et al., 2016), to maintain the cell shape 
and structure that is critical for pathogenesis, most notably host cell invasion (Morrissette 
and Sibley, 2002). In extracellular parasites, we see that the status quo in cortical vs. 
cytoplasmic localization is maintained for the situation at the time of egress for IMC7 and 
14. It is well known that parasites are able to complete cell division in the extracellular 
environment and then end up in G1, leading to a G0 arrest (Gaji et al., 2011; Lescault et 
al., 2010). Our data now show that parasites emerging during G1 largely stay in that stage 
of G1. We interpret this to mean that egressing parasites in which IMC7 and 14 are 
already translocated to the cortex do not revert back to the middle of G1, or at least this 
does not result in the release of IMC7 and 14. On the other hand, for IMC12 we observe 
that the association with the cortex slowly increases with the time spent outside a host 
cell. Germane to this, IMC12 was found to be phosphorylated in a calcium dependent 
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fashion in extracellular parasites in a global phosphoproteomic analysis, but IMC7 and 14 
not (Nebl et al., 2011). It is therefore tempting to speculate that one of the unique calcium 
dependent protein kinases is responsible for this event and furthermore, the 
phosphorylation of Serine residues 249 and 250 facilitates and/or regulates the cortical 
association of IMC12. To test this hypothesis we attempted to complement the 
IMC12dKO line with the auto-fluorescent tagged phosphonull and mimic mutants. 
Unfortunately, these events were not successful and hint at a potential dominant negative 
effect when the parasite is asked to rely on a single YFP tagged IMC12 protein in 
absence of an untagged version. Functionally, we speculated that the translocation of 
IMC12 would be responsible for resisting stresses faced in the extracellular environment, 
but our osmotic shock assays do not provide experimental support in this direction. It is 
again possible that IMC12 acts in concert with other IMC proteins to support this 
function. Indeed the global calcium dependent phosphoproteome analysis also identified 
phosphorylation events in IMC1, IMC3 and IMC6, which all are incorporated in the 
parasites during budding. This again could hint at some form of redundant regulation or 
function. Alternatively, it is possible IMC12 functions in tensile or deformability stress, 
as has been shown in malaria gametocytes (Aingaran et al., 2012; Tremp et al., 2008). On 
the other hand, we show that IMC7 and IMC14, which are not phosphorylated in a 
calcium dependent fashion, function in resistance to osmotic stress. Thus, it is possible 
several parallel mechanisms are at work.  
It is interesting to note that the IMC filament repertoire in Plasmodium parasites 
is much smaller and that in general, only single IMC protein is expressed in particular 
live stages. Stage specific roles for individual IMC proteins have been found in 
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Plasmodium (Tremp et al., 2014). For instance, IMC1a has been shown to be responsible 
for sporozoite size, stability and infectivity while IMC1b is responsible for ookinete 
stability and motility (Khater et al., 2004; Tremp et al., 2008). Toxoplasma appears to 
express a much larger repertoire of IMC proteins in the same live stage and therefore 
appears to have invested in a much more robust and redundant network of IMC proteins. 
Clearly, this is a challenge in the study of these proteins. 
 To assess whether Toxoplasma also expresses stage specific IMC proteins 
with potentially stage specific functions, we assessed the relative abundance of mRNA 
across tachyzoites, bradyzoites, the coccidian cycle in the cat and sporogenesis in the 
extracellular environment. These data are available on ToxoDB as microarray data 
(Gutierrez et al., 2010; Fritz et al., 2012). The expression profiles of IMC7, 12 and 14 
across oocysts, sporozoites, tachyzoites and bradyzoites were collected and plotted in 
Figure 2.9. IMC7 is expressed at low levels in oocysts and sporozoites compared to the 
tachyzoites and bradyzoites stages of the parasite. Interestingly, IMC12 first peaks in the 
mature sporozoites and is maintained at relatively higher level than the other two IMC 
transcripts throughout tachyzoites and bradyzoites stages. Contrastingly, IMC14 has its 
maximum expression in the oocysts and sporulated sporozoites stages and decreases 
through tachyzoites and bradyzoites. Hence, it can be noted that these IMC proteins 
follow a very dynamic expression pattern unique to each life stage, indicating potentially 
stage specific functions as observed in Plasmodium (Tremp et al., 2014). IMC14 may be 
providing stability to the sporozoites stage along with maintaining the division of oocyst 
to sporocysts. It is likely that IMC14 also coordinates meiosis and/or sporogenesis in 
other life stages of Toxoplasma.  
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The most distinct and unexpected discovery of our work was the role of IMC14 in 
the number of offspring produced per division round. In comparison to the wild type 
more than a four fold increase was observed in vacuoles with asynchronous budding and 
multiple daughters within one mother cell. This phenotype is reminiscent of 
endopolygeny in the cat enterocytes during merogony. The difference in number of 
offspring is regulated by the differential inner and outer core replication cycles of the 
centrosome, which controls apicomplexan cell cycle flexibility (Suvorova et al., 2015). 
The inner core controls the nuclear replication cycle while the outer core regulates the 
cytokinetic cycle. Thus, IMC14 somehow slows down or interferes with the outer core’s 
coordination of the cytokinetic cycle during endodyogeny of tachyzoites. This results in 
re-entry into the mitotic cycle without completing cytokinesis and leads to the generation 
of four centrosomes and four daughters in the next cycle. Taken together, through this 
first study to functionally characterize the members of the IMC protein family we found 
evidence for distinct roles for these IMC proteins in tachyzoites.  
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Figure 2.1. Expression patterns of the IMC proteins  
 
(a) Schematic of Intermediate filament-like IMC proteins containing the alveolin repeat 
domain in yellow and the N and C terminal ends in green. Typical cysteine residues are 
marked in red and the asterisks denote predicted palmitoylation sites. (b) Schematic of 
experimentally validated spatiotemporal localization dynamics of all alveolin domain 
IMC proteins (Anderson-White et al., 2011). Groups of IMC proteins with a similar 
behavior are shown in the same color with IMC14 labeling the mature parasite and IMC7 
and IMC12 exclusively in the mother parasite. The extracellular parasite outside the box 
shows the localization of IMC7, 12 and 14 to the mature cortex. (c) The mRNA 
expression level of all alveolin domain IMC proteins throughout two cycles of tachyzoite 
development. Expression of the mature group of IMC proteins peaks in early G1 for 
IMC14 (indicated in yellow) followed by IMC7 (light blue) and IMC12 (navy blue) in 
mid G1. The primary mRNA data (Behnke et al., 2010) was taken from ToxoDB and the 
intensity was normalized as described earlier (Anderson-White et al., 2011).  
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Figure 2.1. Expression patterns of the IMC proteins  
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Figure 2.2. Mature group of IMCs completely transition to the cortex in late G1 
stage 
 
Pictorial representation of procedure employed to arrest the parasite in (a) mid G1 stage 
by temperature restrictions and (b) late G1 stage upon 3-MA treatment. Quantification of 
FV-P6 parasite line expressing mCherry fused to IMC7 (c), IMC12 (d) and IMC14 (e) in 
the cortex of the parasite after invasion at 35°C (permissive, random cycling parasites) 
and mid G1 arrest at 40°C. The percentage of parasites with cortical signal of IMC7 (c), 
12 (d) or 14 (e) is quantified after 3 -MA block in late G1. All graphs are plotted from the 
average percentage of cortical vacuoles counted from three independent experiments by 
quantifying more than 100 vacuoles each time in N=3 ±S.D.   
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Figure 2.2. Mature group of IMCs completely transition to the cortex in late G1 
stage 
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Figure 2.3. Localization of the mature group of IMC proteins in extracellular 
tachyzoites 
 
(a) Quantification of cortical localization of marked IMC signal in extracellular parasites 
at 0, 2 and 24 hrs. Graph is plotted from the average percentage of cortical localization of 
IMC in the extracellular parasites by counting more than 200 parasites in N=3 ±S.D. 
One-way ANOVA showed a significant p < 0.002 for IMC12 between 0-2 hrs and 0-24 
hrs time point.  
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Figure 2.3.  Localization of the mature group of IMC proteins in extracellular 
tachyzoites 
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Figure 2.4. Generation and verification of IMC7 cKD line 
 
(a) Pictorial representation of double homologous recombination to replace the 
endogenous pimc7 promoter with drug selectable marker and regulatable promoter. 
Diagnostic primer pairs are numbered 1-3. (b) Integration PCR1 and 2 to verify the 5’ 
and 3’ flanks as indicated in panel a in the IMC7cKD line and presence of native 
promoter in the parental line shown by PCR3. (c) IFA image showing no IMC7 signal 
after 24 hrs of ATc treatment. IMC1 in green marks the cytoskeleton of the parasites and 
the DNA material is stained by DAPI. (d) Western blots to show IMC7 protein 
downregulation after 24 hrs ATc treatment using α−IMC7. α−tubulin (12G10) is used as 
loading control (lower panel).  
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Figure 2.4. Generation and verification of IMC7 cKD line 
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Figure 2.5. IMC7 is required to maintain parasite rigidity 
 
(a) Plaque assay ±ATc of WT and cKD line after incubating it for 9 days and stained with 
crystal violet.  (b) Percentage of permeabilized cells as stained with PI after treatment 
with 1X HBSS, 0.5 X HBSS, 0.25X HBSS (hypo osmotic) and sorbitol (hyper osmotic) 
in wild type (WT) parasites and IMC7cKD line. N=1.  
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Figure 2.5. IMC7 is required to maintain parasite rigidity 
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Figure 2.6.  Loss of IMC12 is not critical for parasite viability 
 
(a) Schematic of direct knockout line of IMC12 by CRISPR. The genomic locus of 
IMC12 is cleaved by Cas9 (yellow arrows) and replaced by DHFR resistant marker 
flanked by the homologous region of IMC12 (red). Diagnostic PCR primer pairs marked 
I-IV. (b) Verification of correct integration of DHFR cassette in IMC12 locus as 
indicated by PCR I-III and the absence of reintegration of IMC12 randomly in the 
genome as shown in panel for PCR IV. (c) Plaque assay after 8 days incubation stained 
with crystal violet. (d) Percentage of permeabilized cells stained with PI after treatment 
with hypo osmotic and hyper osmotic buffers in wild type (WT) parasites and IMC12 
dKO line. N=1. 
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Figure 2.6. Loss of IMC12 is not critical for parasite viability 
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Figure 2.7. Strategy of IMC14 dKO and its verification by integration PCR  
 
(a) Schematic of IMC14 dKO strategy by double homologous recombination using 
CRISPR/cas9 technology. Cas9 cleaves DNA at the specific sites as marked by the 
yellow arrows. The PCR product of DHFR flanked by the red highlighted homologous 
regions of the IMC14 locus replaces the endogenous locus. The location of diagnostic 
PCR primer pairs is marked I-IV. (b) Diagnostic PCR reactions to confirm the 
replacement of IMC14 locus (Pair I) and the integration of DHFR locus (Pair II and III). 
Pair IV marks the absence of IMC14 gDNA indicating the replaced fragment has not 
randomly reintegrated elsewhere in the genome.  
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Figure 2.7. Strategy of IMC14 dKO and its verification by integration PCR  
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Figure 2.8.  IMC14 is required for both synchronous division and membrane 
rigidity 
 
(a) Plaque assays stained with crystal violet after 8 days of growth. (b) IFA image of 
parental and dKO line stained with α−IMC3 (red), α−hCentrin (green) and DAPI and the 
corresponding phase image. The arrowhead indicates the parasite with 4 budding 
daughters as opposed to 2 in other parasites within the same vacuole. (c) Quantification 
of loss of synchrony in dKO line compared to wild type by blindly counting about 150 
vacuoles in independent experiments. N=3 ± S.D. (d) Increase in percentage of 
permeabilized IMC14 dKO parasites as shown by PI staining in hypotonic (0.25X 
HBBS) and hypertonic (1M Sorbitol) conditions. N=1.  
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Figure 2.8. IMC14 is required for both synchronous division and membrane rigidity 
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Figure 2.9. Transcriptomic analysis of oocyst, sporocysts, tachyzoite and bradyzoite 
development in Toxoplasma 
 
Relative mRNA expression levels of IMC7, IMC12 and IMC14 in oocyst indicated by 
unsporulated and sporulated stages, tachyzoites shown by in vitro for 2 and 4 days and 
bradyzoites from in vitro 8 days and in vivo 21 days.  
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Figure 2.9. Transcriptomic analysis of oocyst, sporocysts, tachyzoite and bradyzoite 
development in Toxoplasma 
 
 
 
 
 	   	  
49	  	  
CHAPTER 3: TOXOPLASMA GAPDH1 IS ESSENTIAL FOR INTRACELLULAR 
REPLICATION 
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3.1. Introduction 
The glycolytic enzyme glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is an 
archetypical multifunctional protein with diverse activities and distinct subcellular 
localization (Sirover, 2011) and yet is relatively unexamined in Toxoplasma. This key 
enzyme (EC 1.2.1.12) of glycolysis catalyzes the oxidative phosphorylation of 
glyceraldehyde 3-phosphate (G3P) to D-glycerate-1, 3-bisphosphate in presence of NAD+ 
and inorganic phosphate. Additional moonlighting functions of GAPDH include 
membrane fusion and transport, cytoskeletal dynamics, iron uptake and transport, heme 
metabolism, post-transcriptional gene regulation, tRNA export, chromatin structure and 
maintenance of DNA integrity. These diverse functions are regulated by a combination of 
post-translational modifications, subcellular localization, conformation dynamicity and 
protein complex assembly (Tristan et al., 2011). For example, human GAPDH facilitates 
actin polymerization and microtubule bundling by interacting with tubulin and actin 
(Kumagai and Sakai, 1983; Reiss et al., 1996). GAPDH is phosphorylated by an atypical 
protein kinase and recruited to Rab2-coated vesicular tubular clusters to facilitate 
vesicular retrograde trafficking along microtubule tracks powered by motor protein 
dynein (Tisdale et al., 2009). A phosphatidylserine-rich binding domain (PSB) localized 
in the N-terminus of GAPDH is a catalyst for membrane fusion (Nakagawa et al., 2003). 
The moonlighting roles of GAPDH appear to be uncoupled from its primary function in 
glycolysis (Tisdale et al., 2004). 
 To partition the complex GAPDH functions, we take an uncommon approach thus 
far in Toxoplasma research by combining structural information to correlate its functional 
analysis. With help of our collaborators at Seattle Structural Genomics Center for 
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Infectious Disease, WA, the X-ray crystallographic analysis of GAPDH1 protein 
structure was determined. This provided the precise, structural reflection board for a 
thorough molecular dissection of role of GAPDH1 in the parasite lytic cycle. The 
crystallographic structure of GAPDH is well documented across several biological 
kingdoms and the enzymatic mechanism is well studied but the structural basis of its non-
glycolytic functions has not been completely explored. GAPDH is a homologous tetramer 
(~150 kDa) of O-R subunits that exhibits three asymmetric P, Q and R dyads (Roitel et 
al., 2003). This bilobal structure is universally conserved with the folding of an N-
terminal NAD+-binding domain and a C-terminal G3P catalytic domain (Jenkins and 
Tanner, 2006). 
 It has been established that glycolysis is not strictly essential in Toxoplasma 
(Blume et al., 2009; MacRae et al., 2012) and that the extracellular parasites do not 
require carbon source uptake in the first hour of their extracellular life (Lin et al., 2011). 
It was also reported that upon parasite egress glycolytic enzymes translocate from the 
cytosol to the cortex after about an hour in the extracellular stage (Pomel et al., 2008). It 
was hypothesized that the close association of the glycolytic enzymes to the pellicle is 
related to the highly localized production of ATP in the extracellular parasites for 
improved delivery of ATP by the active transporter mechanisms in the parasite plasma 
membrane and to the motile apparatus situated in the space between plasma membrane 
and IMC (Pomel et al., 2008).  
 In this part of the thesis we have established that knockdown of GAPDH1 
expression and catalytic site disruption validate the essentiality of GAPDH1 in 
intracellular replication of the parasite. Complementing it with both small and large 
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fusions can restore the function of GAPDH1 in the parasite. The relocation of GAPDH1 
is blocked in presence of bulky tags due to steric hindrance but the viability of the 
parasite is not disrupted. It is possible that overexpression of these large fusion tags 
causes spurious cytoplasmic localization of GAPDH1 in the extracellular stage. 
Nevertheless, GAPDH1 is critical for parasite viability and active site mutation is not 
able to restore this phenotype.  
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3.2. Results  
3.2.1. GAPDH1 is a tetrameric structure  
The Toxoplasma genome database (ToxoDB, http://toxodb.org) (Gajria et al., 2008) 
indicates that GAPDH1 (TGME49_289690) and GAPDH2 (TGME49_269190) are both 
constitutively expressed in tachyzoite and bradyzoite stages. While the GAPDH2 
isoenzyme is targeted to the apicoplast organelle (Fast et al., 2001), GAPDH1 is cytosolic 
in intracellular parasites (Pomel et al., 2008). The crystal structure of TgGAPDH1 was 
determined to 2.25Å resolution in the holoenzyme NAD+-bound state (Dubey et al., 
2016). The GAPDH fold was validated by DALI analysis of the Toxoplasma GAPDH1 
structure and reveals its close similarity to the GAPDH oxidoreductase folds with the top 
scoring hit of Cryptosporidium parvum GAPDH (Z-score 55.4, PDB ID 3CIF) (Cook et 
al., 2009). The secondary, tertiary and quaternary structures of Toxoplasma GAPDH1 are 
very similar to GAPDH structures that have been previously reported (Figure 3.1. and 
Figure 3.2. a-b).   
 The tetramer exhibits approximate 222-symmetry (Table 3.1.) with each bilobal 
subunit composed of a NAD+-binding domain (residue 4-152, 320-340, Pfam PF00044) 
and a catalytic domain (residue 153-319, Pfam PF02800). One NAD+ cofactor is bound 
per monomer and the average root-mean-square distance (r.m.s.d.) between monomers 
over all atoms is 0.02 Å as calculated by PISA. The GAPDH1 tetramer exhibits a 
dihedral symmetry with 3 axes of ‘symmetry’ (P, Q, R) in which only the P axis is a true 
symmetry (Figure 3.2. b) (Dubey et al., 2016). The O-R and P-Q dimers are however the 
most important for optimization of enzymatic activity, since the S-loop (residue 180-207) 
inserts into the NAD+-binding cavity of the adjacent subunit (Figure 3.2. and 3.8.). The 
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most distinct structural feature from human GAPDH is the Lys-Gly dipeptide insertion 
(Figure 3.2. a) in the S-loop that is also reported in other apicomplexan parasites (Figure 
3.1.) (Cook et al., 2009; Robien et al., 2006). 
 
 
3.2.2. GAPDH1 relocates to the cortex in extracellular parasites 
 
Toxoplasma GAPDH1 and other glycolytic enzymes are smoothly distributed in the 
cytosol in intracellular parasites and are translocated to the pellicle of the parasite upon 
egress from the host cell (Pomel et al., 2008). This phenomenon was observed only with 
a small fusion tags but not with large tags like mCherry or YFP. We repeated this study 
specifically for GAPDH1, with a tandem small c-Myc tag (Myc2: 26 amino acid) and a 
large YFP or mCherry (GFP: 238 amino acids, mCherryRFP: 226 amino acids) fusion 
tags at N terminus of the protein. In the intracellular parasites, our IFA results using Myc 
antibody show a cytosolic localization and in the extracellular parasites there is a clear 
cortical association (Figure 3.3. a). The YFP fusions bleached instantly making 
microscopy difficult but the mCherry fusion clearly shows cytosolic localization in both 
intracellular and extracellular parasites (Figure 3.3. b).  Similarly, we also created C-
terminus fusions and observed a similar phenotype indicating that this is not an artifact of 
N-terminal fusion tags (data not shown).  
 
 
3.2.3. GAPDH1 is essential for the lytic cycle  
To probe the essentiality of GAPDH1 for the Toxoplasma gondii lytic cycle, a GAPDH1 
conditional knockdown line (GAPDH1cKD) was generated by replacing the endogenous 
promoter with anhydrous tetracycline (ATc) regulatable minimal TetO7Sag4 promoter  
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(Figure 3.4. a-b) (Dubey et al., 2016; Meissner et al., 2002).  Expression of GAPDH1 
protein in the GAPDH1cKD parasite line decreases upon ATc addition and becomes 
undetectable within three days of ATc addition (Figure 3.4. c). Plaque assays show that 
GAPDH1 is essential for completion of the lytic cycle (Figure 3.5. a). Cytoplasmic YFP 
expressing lines of parent and GAPDH1cKD lines were produced to complement these 
results and acquire detailed growth kinetics. GAPDH1cKD parasites do not grow in 
presence of ATc (Figure 3.5. b). Furthermore, microscopic evaluation was used to 
pinpoint the exact point of arrest in parasite development. In the presence of ATc, 
GAPDH1cKD parasites replicate at a similar rate to the parent line control up to 60 hrs, 
at which point the mutant arrests and no further growth is observed (Figure 3.5. c). The 
parasites arrest while residing in the vacuole without any discernable morphological 
defects (Figure 3.5. c inset).  
 We also determined whether GAPDH1 is required for invasion or egress by 
growing parasites for 60 hrs in the presence of ATc when protein is down regulated. 
Egress is stimulated by Ca2+-ionophores, whereas invasion is tested by physically 
releasing parasites from the host cell and testing them for re-invasion of fresh host cells. 
Invasion and egress are not significantly inhibited in absence of GAPDH1 (Figure 3.6. a-
b). The data demonstrate that GAPDH1 is essential for intracellular replication, but is not 
required to support invasion or egress (Dubey et al., 2016). 
 
 
3.2.4. Relocation of GAPDH1 is not essential for parasite viability 
In our optimization of protein reporter tags for GAPDH1, we first genetically 
complemented the GAPDH1cKD line with both small and large fusion tags.  Wild-type 
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GAPDH1 (WT) was fused to Myc2, YFP and mCherry. Upon quantification of cortical 
localization we observed that fusion of bulky fluorophores at the N-terminus block 
translocation of GAPDH1 to the cortex in extracellular parasites, whereas the smaller 
tandem Myc2 epitope tag does not (Figure 3.7. a). Interestingly this blocking of 
translocation with bulky fusions of both YFP and mCherry did not impair the viability of 
the parasites indicating relocation is not essential for the parasite survival (Figure 3.7. b).  
 
3.2.5. GAPDH1 catalytic site is essential for activity but not translocation 
The active site pocket of Toxoplasma and Cryptosporidium GAPDH is identical in the 
G3P residues that form hydrogen bonds with the substrate (S152, T154, T214, G215, 
N319 in Figure 3.8. a-b). The conserved NAD+-binding residues include I13, D34, R12, 
K79 and S121. The NAD+ binding mechanism in Toxoplasma GAPDH1 appears to be 
stronger than Cryptosporidium GAPDH in forming addition hydrogen bonds between 
residues K79 and N6A of NAD+ (3.1 Å) and hydrophobic interactions between N319 and 
N7N of NAD+ (2.8 Å). Highly conserved in Toxoplasma GAPDH1 are the catalytic C152 
and H180 residues, which mediate the nucleophilic attacks of carbonyl groups (Figure 
3.8. a). 
 The essentiality of the Toxoplasma GAPDH1 enzymatic activity was evaluated by 
generating a point mutation of the catalytic cysteine (C152G) (Cook et al., 2009). The 
GAPDH1cKD line was genetically complemented with an allele encoding a tandem 
Myc2 tagged C152G mutant of GAPDH1.  Glycolysis is required for parasite viability 
since parasite growth is readily rescued by the WT construct but the C152G allele is 
unable to restore growth (Figure 3.9. a). We also performed a western blot to confirm the 
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downregulation of GAPDH1 in the GAPDH1WT complemented line after ATc treatment 
(Figure 3.9. b). Additionally, GAPDH1C152G also translocates to the cortex of the 
extracellular parasites (Figure 3.10.) similar to GAPDH1WT indicating that integrity of 
active site is not required for this function. 
 
3.2.6. Glycolysis is bypassed in absence of GAPDH1 
It has been reported that glycolysis can be bypassed by glutaminolysis, as glycolytic 
intermediates are essential for lipid biosynthesis (Blume et al., 2009).  Using a monolayer 
lysis assay and cell replication assay we observe that in GAPDH1C152G complementation 
line growth can be restored by glutamine supplementation, but glutamine cannot 
completely restore the GAPDH1cKD parasites (Figure 3.11. a and b). Direct 
measurement of GAPDH activity in the parasite indicated a dramatic reduction in the 
GAPDH1cKD line that was comparable to the loss of GAPDH activity in the 
GAPDH1C152G complemented line (Figure 3.11. c). This also implies that GAPDH2 does 
not compensate for the loss of GAPDH1 even if the protein scaffold is present. 
Additionally, the high level of GAPDH activity compared to the parental line in the 
GAPDH1WT is not due to the presence of native GAPDH1 as it is clearly down regulated 
after 60 hrs of ATc treatment (Figure 3.9. b).  
 To further validate that glycolysis is not essential the overall ATP concentration is 
measured, as done for other Toxoplasma glycolysis mutants (Starnes et al., 2009). The 
ATP level significantly decreases in the GAPDH1cKD and GAPDH1C152G complemented 
line but not the parent or GAPDH1WT complemented line  (Figure 3.11. d). Hence, the 
catalytic activity of GAPDH1 is only critical for the glycolytic role of GAPDH1 in the 
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parasites and is essential for parasite growth under normal conditions. The GAPDH1 
protein scaffold if essential for other functions are not critical in the parasites (Dubey et 
al., 2016).  
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3.3. Discussion 
 The crystal structure of GAPDH1 combined with the post-translational 
modification data and allelic replacement of active site confers its role in glycolysis. 
Several studies have shown that glycolysis is not strictly essential in Toxoplasma (Blume 
et al., 2009; MacRae et al., 2012), which is also confirmed by our glutamine rescue data. 
Although our initial data indicated that GAPDH1 is essential, we show that L-glutamine 
complementation rescues parasite viability to approximately 50%. This partial rescue is 
consistent with the contribution of glycolysis intermediates to lipid synthesis, which is 
growth limiting (Nitzsche et al., 2015; Ramakrishnan et al., 2015). Loss of GAPDH1 
activity results in the loss of glycolysis, which is essential for parasite growth under 
normal conditions. Since we observe a trend of increased rescue upon complementation 
of the complete knockdown with the C152G mutant (albeit not statistically significant), 
we conclude that there is a hint of moonlighting function(s) of GAPDH1 in the 
Toxoplasma lytic cycle.  
GAPDH1, a quintessential multifunctional protein, translocates intriguingly to the 
unique cortical membrane skeleton. Bulky tags at GAPDH1 termini most likely interfere 
the interactions with other proteins and complex of the cortical translocation machinery. 
However, the phenotype of the GAPDH1cKD is rescued by complementation using the 
large fusions of YFP or mCherry tags. The N-terminus of GAPDH1 protrudes on the 
surface and could play a role in membrane association that might be blocked by steric 
hindrance in presence of a large tag. Cortical translocation is nonetheless decoupled from 
glycolytic essentiality. It has been shown that after prolonged extracellular gliding stored 
ATP becomes depleted (MacRae et al., 2012) and therefore ATP production at the cortex 
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becomes much more critical in such situation. However, parasite can easily convert other 
carbon sources to produce energy to survive. The catalytically dead mutant is 
translocated similar to WT complementation, indicating that this phenomenon is 
uncoupled from glycolysis. Thus, though GAPDH1 is critical for intracellular replication 
of the parasite, using our structure-function analysis we have discovered that 
translocation of GAPDH1 is not essential for parasite viability.  
The complemented Myc-tagged GAPDH1 with or without ATc treatment have 
relatively similar GAPDH activity and translocate to the cortex upon parasite egress. 
Moreover, the GAPDH1 active site mutant is also readily relocated to the cortex though 
is not active. It is important to note that although in our complementation experiments the 
protein levels is relatively similar, it is possible that the overexpression of cytosolic 
GAPDH1 is able to overcome specific membrane association, as has been shown for 
CDPK3 kinase anchored to the IMC (Garrison et al., 2012). Overall, our data show that 
glycolytic activity is prime role of GAPDH1 but is not related to cortical translocation.   
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Table 3.1. Crystal structure data of TgGAPDH1 Crystal structure data collection and 
refinement statistics of Toxoplasma GAPDH1, PDB code 3STH. Values in parentheses 
are for highest-resolution shell. 
 
  
Data collection  
Space group P 21 21 21 
Cell dimensions    
    a, b, c (Å) 103.37, 104.32, 146.63 
    a, b, g  (°)  α, β, γ = 90 
Resolution (Å) 50-2.25 (2.29-2.25) 
Rsym or Rmerge  
I / sI  
Completeness (%) 99.7 (98.7) 
Redundancy 5.6 (5.7) 
  
Refinement  
Resolution (Å) 50.0-2.25 (2.31-2.25) 
No. reflections 75385 (5199) 
Rwork / Rfree 0.172/0.216 (0.221/0.299) 
No. atoms  
    Protein 10169 
    Ligand/ion 232 
    Water 751 
B-factors  
    Protein 23.88 
    Ligand/ion 27.76 
    Water 17.54 
R.m.s. deviations  
    Bond lengths (Å) 0.011 
    Bond angles (°) 1.277 
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Figure 3.1. Secondary structural alignment of GAPDH 
 
Apicomplexan parasite (Toxoplasma gondii, Plasmodium falciparum, Cryptosporidium 
parvum), plant chloroplast (spinach), bacterium (Staphylococcus areus) and human 
GAPDH (somatic and sperm) are aligned to the Toxoplasma backbone using ESPript 3.0. 
The two domains as indicated function in NAD+ binding and catalysis. Dashed box 
indicates the Lys-Gly dipeptide insertion (DI) in apicomplexans that sets it apart from 
higher eukaryotic GAPDH. Functional residues are identified as C (catalytic residues), P 
(Phosphorylation), Pa (Palmitoylation), A (Acetylation), G (O-linked N-acetyl 
Glucosamine), PSB  (PhosphatidylSerine-rich Binding), NE (Nuclear Export), and GB 
(Glutathione Binding).  P, Pa and C residues that have been mutagenized for functional 
assays in this study are underlined. Residues that form hydrogen, hydrophobic and both 
types of bonds with the cofactor NAD+ are labeled in orange, respectively as H, h and H. 
Similar labels in green are used for residues that bond with the substrate G3H. Sequences 
were extracted from UniprotKB database: T. gondii GAPDH1 (code Q9BKE2), C. 
parvum GAPDH (code Q7YYQ9), P. falciparum GAPHDH (code Q8T6B1), Homo 
sapiens (human) GAPDH1 (somatic, code P04406), H. sapiens (human) 
GAPDH2/GAPDHS (sperm, code O14556), Spinacia oleracea (spinach) chloroplast 
GAPDH (code P19866). Crystallographic structures of the seven selected GAPDH 
proteins are solved and deposited in PDB. 
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Figure 3.1. Secondary structural alignment of GAPDH 
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Figure 3.2. Structure of TgGAPDH1 protein 
 
(a) Crystallographic structure of Toxoplasma GAPDH1 monomer showing the catalytic 
and NAD+-binding domain with a dipeptide insertion (DI) in the S-loop that is unique to 
apicomplexan parasites. (b) GAPDH1 tetramer exhibits a true axis of symmetry (P axis) 
(bottom row) and two pseudo (top row) symmetrical axes (Q and R axes).   
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Figure 3.2. Structure of TgGAPDH1 protein 
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Figure 3.3. GAPDH1 is relocated to the cortex in extracellular parasites 
 
(a) IFA of intracellular and extracellular parasites with c-Myc2 GAPDH1 fusions using 
α-Myc for visualizing GAPDH1 localization, α−IMC3 to stain the cortical cytoskeleton 
and DAPI to stain the nuclear material. (b) Live microcopy images of intracellular and 
extracellular mCherry GAPDH1 fusion at N-terminus.  
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Figure 3.3. GAPDH1 is relocated to the cortex in extracellular parasites 
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Figure 3.4.  Generation and verification of GAPDH1cKD 
 
(a) Schematic of GAPDH1cKD generation. GAPDH1cKD was generated in the 
TATiΔku80 parental line using the tet-repressible system. A DHFR selectable cassette 
containing TetO7Sag4 (T7S4) replaced the endogenous promoter of GAPDH1 by double 
homologous recombination in the 3’HR and 5’HR regions. PCR1-3 regions indicate the 
diagnostic PCRs to determine correct integration as determined in panel b. (b) Integration 
PCR shows that endogenous promoter is disrupted. Localization of diagnostic PCR 
primer pairs provided in panel a. (c) Western blot indicates progressive loss of GAPDH1 
protein expression in the GAPDH1cKD parasite line. Parasites were treated with ATc for 
the indicated time periods. GAPDH1 was detected with anti human GAPDH. A 
monoclonal antibody recognizing cortical cytoskeleton protein IMC1 was used as a 
loading control. 
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Figure 3.4.  Generation and verification of GAPDH1cKD 
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Figure 3.5. Phenotypic analysis of GAPDH1cKD 
 
 (a) Plaque assay of parasites grown in the absence (-) and presence (+) of ligand 
anhydrotetracycline (ATc, 1.0 µg/ml) for 10 days on HFF monolayer indicates that 
GAPDH1cKD parasites were not viable. (b) Growth assay measures cytosolic YFP 
fluorescence expressed in parasite strains and shows that GAPDH1cKD parasites did not 
exhibit growth up to 8 days. (c). Replication assay by microscopic quantification of 
number of parasites per parasite vacuoles demonstrates that GAPDH1cKD parasites did 
not replicate further following 60 hrs of induction. Inset shows a vacuole containing four 
morphologically normal parasites at 96 hrs of ATc induction. More than 100 vacuoles 
were counted for N=3 ± s.e.m. statistical significance calculated by paired, two tailed t-
test, **P < 0.02. 
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Figure 3.5. Phenotypic analysis of GAPDH1cKD 
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Figure 3.6. GAPDH1 is not required for invasion or egress of the parasite 
 
(a) Invasion assay shows that there is no significant invasion defect. Over 200 parasites 
per condition were counted to calculate percent invasion and statistical analysis was done 
by the paired two-tailed t-test. N=3 ± s.e.m. (b) Egress assay shows that loss of GAPDH1 
does not impair egress. Calcium ionophore A23187 (2 µM) was used to induce egress of 
GAPDH1cKD and TATiΔku80 parasites after 60 hrs of ATc treatment from the host cell. 
15 random fields were counted in N=3 ± s.e.m.  
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Figure 3.6. GAPDH1 is not required for invasion or egress of the parasite 
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Figure 3.7.  Relocation of GAPDH1 is not essential for viability  
 
(a) Cortical localization of N-terminally Myc2 and mCherry fused GAPDH1WT was 
quantified in the extracellular parasites after counting about 200 parasites in N=3 ± S.D.  
t-test,  ***P < 0.0001. Representative image corresponding to the N-terminally fused 
GAPDH1 with either Myc2 or mCherry. The image of mCherry tagged GAPDH1 (red) is 
live in extracellular parasites while methanol fixed and probed using α-Myc (green) for 
Myc2-GAPDH1. (b) Plaque assay of parasites expressing N-terminally-tagged 
fluorescent fusion of mCherryRFP or YFP to Toxoplasma GAPDH1WT after 8 days 
incubation.  
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Figure 3.7. Relocation of GAPDH1 is not essential for viability  
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Figure 3.8. Structure of Toxoplasma GAPDH1 catalytic site 
 
(a) Superimposition of essential residues that interact with substrate G3P and co-factor 
NAD+ in the active site of Toxoplasma and C. parvum (PDB code 3CIF) GAPDH.  
Residues that form hydrogen and hydrophobic bonds are colored yellow for C. parvum 
and deep teal for Toxoplasma. Catalytic residues of G3P are coded as red (C. parvum) 
and green (Toxoplasma). C. parvum structure has a C151S variant. Unique residues that 
can form hydrophobic interactions with NAD+ in Toxoplasma GAPDH1 are illustrated in 
purple. (b) Supposition of S-loops in Toxoplasma GAPDH1 shown in deep teal (R 
subunit) and human somatic GAPDH that is expressed in human brain cells are shown in 
red (PDB code 1ZNQ).   
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Figure 3.8. . Structure of Toxoplasma GAPDH1 catalytic site 
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Figure 3.9. Active site mutation is lethal for the parasite 
 
(a) Complementation of GAPDH1cKD was observed with wild type GAPDH1 but not 
with active site mutant C152G as shown by plaque assay for 10 days.  (b) Western blot to 
ascertain that the native GAPDH1 is the down regulated in the complemented lines upon 
ATc treatment. Top panel shows endogenous GAPDH1 and the Myc tagged fusion using 
α-human GAPDH and the middle panel shows the fused Myc2-GAPDH1 as shown by α-
Myc antisera. Bottom panel is loading control shown by α-IMC1.  
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Figure 3.9. Active site mutation is lethal for the parasite 
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Figure 3.10. Active site of GAPDH1 has no role in translocation 
 
Intracellular and extracellular parasites showing localization of GAPDH1 in the Myc2 
tagged GAPDH1C152G variant after methanol fixation. Shown in green is α-Myc staining 
of tagged Myc2-GAPDH1 and in red is α-IMC3 staining of cortical cytoskeleton, Nuclear 
material is stained with DAPI.  
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Figure 3.10. Active site of GAPDH1 has no role in translocation 
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Figure 3.11. Functionality of GAPDH1 active site  
 
(a) Cell monolayer lysis assay measures the capacity of GAPDH1cKD, GAPDH1WT and 
GAPDH1C152G to proliferate and lyse the host cell monolayer in presence of glutamine 
replete vs. glucose replete-media. Post 48 hrs incubation the monolayer was fixed and the  
absorbance after crystal violet staining was measured. One representative experiment of 
three biological replicates is shown. N=3 ± S.D. (b) Replication assay was done and 
parasite numbers per vacuole were counted for more than 100 vacuoles and expressed as 
number of cell divisions post infection in glutamine replete or glutamine-deplete media. 
N=3 ± s.e.m. t-test, **P < 0.02, ***P < 0.002 (c) GAPDH activity as calculated by 
measuring the reduction of NADH illustrates the conditional knockdown and catalytic 
residue mutation inhibit activity. d) ATP measurement was determined by the total 
amount of ATP per parasite for the parasite lines as indicated grown ± ATc for 60 hrs.  
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Figure 3.11. Functionality of GAPDH1 active site 
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CHAPTER 4: ALLOSTERIC REGULATION OF TOXOPLASMA GAPDH1 BY 
PHOSPHORYLATION 
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4.1. Introduction 
GAPDH is a highly conserved protein with little variance from species to species 
(Sirover, 1999). Toxoplasma GAPDH1, similar to others, is a tetramer with four 
independent subunits O, Q, R and P containing the coenzyme NAD+ (Dubey et al., 2016). 
GAPDH1 is composed of two folding domains, NAD+ binding domain and the catalysis 
domain. Within the catalytic domain is a S-shaped loop called the S-loop, composed of 
the amino acid residue from position 180 and 210 (Figure 3.1.)  The S-loop forms the 
core of the four subunits and is in contact with NAD+ on the R-axis and several amino 
acids across the P-axis. It is pivotal for co-factor binding, allosteric activation and 
quaternary structure assembly (Biesecker et al., 1977). Interestingly, the 
phosphoproteome of Toxoplasma provides evidence for the phosphorylation of two 
residues associated with the S-loop of GAPDH1, Ser50 and Ser203 (Treeck et al., 
2011a). While Ser50 is highly conserved residue in all across different phylum including 
humans (Akinyi et al., 2008), Ser203 is unique to Toxoplasma and some closely related 
coccidians like Hammondia and Neospora (ToxoDB).  
 It has been known since the early 1950s that GAPDH catalyzes the oxidative 
phosphorylation of D-glyceraldehyde 3-phosphate to 1, 3-disphosphoglycerate in the 
presence of NAD+ and inorganic phosphate (Segal and Boyer, 1953). The homotetramer 
exhibits a dimerization interface as well as subunit- subunit interactions that occur as 
dimerized units interact to form the tetrameric structure (Biesecker et al., 1977; Moras et 
al., 1975). Studies over two decades show that GAPDH is also a multifunctional enzyme 
with distinct subcellular localizations and diverse activities (Sirover, 1999, 2011). The 
post-translational modifications are one of the driving forces that modulate the functional 
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diversity of GAPDH (Sirover, 2011). Phosphorylation of GAPDH is functionally relevant 
for cytotoxic T-lymphocyte mediated cytotoxicity, cellular trafficking and stress response 
in cells (Tristan et al., 2011). 
 In this part of the thesis, we have generated phosphomutant-complemented lines 
to better understand the significance of serine phosphorylation events in the S-loop. We 
discovered that dynamic phosphorylation of S50 is required for parasite viability. The 
phosphomimic form of S203 significantly reduces GAPDH activity likely due to 
disrupting the possibility for GAPDH1 to form tetramers (Dubey et al., 2016).   
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4.2. Results 
 
4.2.1. S-loop of GAPDH1 is phosphorylated 
The GAPDH1 S-loops form a two-plier ridge that separates the NAD+-binding cavities of 
subunits across the R axis (Figure 4.1. a-b). Binding of NAD+ increases the ordering of 
the S-loop and interactions between subunits that are positioned across each other in the 
tetramer, leading further to changes in the packing environment at the dyad interfaces 
(Figure 3.1. a). The opening to the NAD+ cavity is more constricted in Toxoplasma 
GAPDH1 in comparison to human GAPDH due to Lys196 and the bulge created by the 
Lys193-Gly194 dipeptide insertion (Figure 4.1. b). Serine 50 is located on the surface 
loop that follows α-helix 2 (α2) and can form hydrogen bonds with the S-loop of the 
neighboring subunits of the Q-R dyad (Figure 4.1. a). Ser50 in the O subunit can form 
contacts with Ser287 in the Q subunit and Asp189 in the S-loop of R subunit. Serine 203 
is located directly in the S-loop and can form hydrogen bonds with three S-loop residues 
(Thr187, Asp189, Asn207) to configure this flexible loop (Figure 4.3. b). The novel 
observation of GAPDH1 S-loop phosphorylation was examined (Treeck et al., 2011a) for 
potential regulatory effects by measuring its effect on parasite viability, cortical 
localization of GAPDH1 in extracellular parasites and GAPDH activity in the 
phosphomutant parasites. 
 
4.2.2. Dynamic phosphorylation of Ser50 is critical for viability 
To assess the impact of these phosphorylation events on various aspects of the parasite’s 
biology we generated parasites lines expressing phosphomimetic (Ser to Glu) and 
phosphonull (Ser to Ala) point mutations. The alleles were evaluated by genetic 
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complementation of the GAPDH1cKD line, where the wild type allele can be down 
regulated by addition of ATc so the effect of the mutant allele can be assessed. We first 
performed plaque assays to evaluate effects on viability. GAPDH1S50E and GAPDH1S203E 
did not support parasite growth as is evident by the absence of vacuoles in the ATc 
treated lines (Figure 4.2.). Additionally, the GAPDH1S50A phosphonull mutation did not 
support viability but the S203A allele confers complete viability (Figure 4.2.). Parasites 
stably expressing the double phosphomimetic mutation (GAPDH1S50E, S203E) could not be 
established in the uninduced GAPDH1cKD line, suggesting that this allele has a more 
severe phenotype and probably acts in a dominant negative fashion (Dubey et al., 2016).  
 
4.2.3. GAPDH1 translocation is independent on serine phosphorylation  
Since kinase activity is associated with egress (Garrison et al., 2012), we asked whether 
phosphorylation of these serine residues in the S-loop of the GAPDH1 are involved in 
cortical translocation. Using the ATc treated mutant parasite lines we did an IFA on the 
extracellular parasites and quantified the percentage of cortical localization of GAPDH1 
mutant.  The parasites were scored with either cortical (Figure 4.3. a) or cytosolic (Figure 
4.3. b) signal of myc-tagged GAPDH1 mutants as shown by the intensity profiles. Upon 
quantification, the N-terminally myc tagged GAPDH1WT used as control for the assay, 
showed cortical localization in 83% of extracellular parasites, indicating that GAPDH1 is 
relocated to the cortex in these parasites (Figure 3.7. a). Interestingly, none of the 
phosphomutants displayed a dramatic translocation defect, although the phosphonull 
mutants trend to show slightly less translocation (Figure 4.3. c). Overall, these data 
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demonstrate that serine phosphorylation is not the major mechanism regulating relocation 
of GAPDH1 to the cortex.  
 
4.2.4. Disruption of S-loop decreases GAPDH1 activity 
Next we assessed whether S-loop phosphorylation had effects on GAPDH1 enzymatic 
activity. The activity of the phosphomutant complemented lines was measured in parasite 
lysates and expressed as GAPDH units/par. Interestingly, no decrease in activity for the 
S50E or S50A mutant was observed upon ATc treatment compared to the S203E. This 
data indicates that GAPDH1 activity is regulated by dynamic phosphorylation of S50 and 
both GAPDH1 dimers need to be in different phospho states for complete GAPDH 
activity (Figure 4.4. a). However, GAPDH1 activity is similar to wild type 
complementation in case of S203A mutant but decreases significantly upon S203E 
complementation (Figure 4.4. a). We verified that GAPDH activity was independent of 
GAPDH1 protein level in the experimental lines (Figure 4.4. b). Although expression 
levels for all mutant proteins were comparable, we detected a slightly shorter version of 
the S203A mutant as well as some smaller protein bands suggesting GAPDH1S203A might 
not be stable. Overall, our observations show that serine phosphorylation of the S-loop in 
GAPDH1 regulates its enzymatic activity, probably by interference with oligomerization 
assembly and allosteric activation (Dubey et al., 2016). 
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4.3. Discussion 
 
Our data illustrates that the dynamic S-loop of Toxoplasma GAPDH1 is regulated by 
differential phosphorylation of Ser50 and Ser203 to trans-activate the catalytic pocket of 
other subunit in the R dyads. Our structure-function data show that dephosphorylated 
S203 is pivotal for reconfiguring the S-loop to fit into the neighboring NAD+-binding 
pocket by forming atomic interactions with three other S-loop residues (Thr187, Asp189, 
Asn207). Dephosphorylated S50 contributes to homodimerization by hydrogen bonding 
across the dimer interface with S287 and stabilizes the neighboring S-loop by bonding 
with Asp189. The phosphorylation events modulate the dynamic motion of S-loop in 
regulating the NAD+-binding pocket and oligomer assembly. Glycolysis appears to be 
regulated by the S-loop phosphorylation as is evident from the decrease in GAPDH 
activity for the constitutive phosphorylated form of Ser203 (Dubey et al., 2016).  
 Dynamic phosphorylation of S50 and mimic of S203 affect viability of the 
parasite. Lytic cycle of the parasite is not disrupted in the absence of phosphorylation of 
S203. This suggests that phosphorylation of the S-loop of GAPDH1 controls glycolytic 
activity and henceforth the parasite viability. There appears to be a direct correlation 
between GAPDH1 activity and viability of the parasite and also the oligomer assembly of 
GAPDH1. However, based on our data the role of S50 in non-glycolytic roles of 
GAPDH1 cannot be eliminated and further research may throw some light on this feature. 
Importantly, the phosphorylation of S-loop has no effect on cortical translocation of 
GAPDH1 in the parasite. Since GAPDH1 translocation occurs upon egress of parasite 
which occurs due to increase in and the GAPDH1 phosphorylation is not calcium 
dependent (Treeck et al., 2011a) so it is not surprising that we did not observe any 
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significant loss of GAPDH1 translocation indicating that a novel mechanism in underplay 
for translocation of GAPDH1 in Toxoplasma.  The specific functions of these serine 
residues further stress the significance of unique post-translational modifications in the 
diverse roles of GAPDH1. Interestingly, the other phosphorylation residue responsible 
for an array of function ranging from cytotoxicity, cellular trafficking and stress response 
in mammals is not predicted in Toxoplasma GAPDH1 (Treeck et al., 2011a).  
 GAPDH1 S-loop phosphorylation is possibly a universal feature since S50 is a widely 
conserved residue across GAPDH proteins from different species (Figure 1). The 
localized effect of catalytic loop phosphorylation on enzymatic activity is a widely 
conserved mechanism. Hallmark examples include the cis-phosphorylation in the 
activation loop of the Ephrin subfamily of tyrosine kinase receptors (Overman et al., 
2014), phosphorylation of the activation loop in the family of MAP kinases (Akella et al., 
2010), and the activation of Aurora A kinase by phosphorylation of its activation loop 
(Zorba et al., 2014). The allosteric regulation of the Toxoplasma GAPDH1 S-loop by 
multiple intra- and inter-phosphorylation events is a novel mechanism of catalytic loop 
activation in this class of enzymatic activity regulation (Dubey et al., 2016). Quite 
surprisingly, no report of GAPDH activity regulation by S-loop phosphorylation has been 
reported in other systems for this well studied protein. This study also reveals unique 
amino acid modifications within the S-loop with functionally important roles and 
provides attractive targets for therapeutic intervention.  
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Figure 4.1. Serine phosphorylation in the regulatory S-loop  
 
(a) Carbon chain and surface rendering of dimer of the R and Q dyads (O-R, top panels, 
O-Q, bottom panels) reveals that phosphorylatable Ser50 (magenta) is located on a beta-
turn that forms 3 hydrogen bonds with Asp189 residue in the S-loop of adjacent subunit 
in the O-R dimer. Ser50 of in the α 2 helix also forms a polar contact with Ser287 (cyan) 
at the interface of O-Q dimer. (b) Phosphorylatable Ser203 is positioned in the S-Loop 
and is critical to the loop stability by forming polar contacts with three residues (Thr187, 
Asp189, and Asn207).   
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Figure 4.1. Serine phosphorylation in the regulatory S-loop  
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Figure 4.2. Dynamic S50 phosphorylation is required for complementation capacity 
  
 Plaque assay after 9 days shows the viability of the phospho-mimic and phospho-null 
mutants by genetic complementation of a parasite line wherein expression of the 
endogenous GAPDH1 locus can be down regulated by addition of ATc. The assay was 
done with a negative control of GAPDH1cKD and a positive control of wild type 
GAPDH1 complementation not shown in the figure.  
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Figure 4.2. Dynamic S50 phosphorylation is required for complementation capacity 
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Figure 4.3. Cortical translocation is not effected by phosphomutants  
 
(a) Representative example of cortical localization (green: α-Myc staining of tagged 
Myc2-GAPDH1; red: α-IMC3 staining of cortical cytoskeleton). The yellow arrow marks 
the site of the intensity profile of both signals.  (b) Representative image indicating the 
cytosolic localization of mutant GAPDH1 in extracellular parasites with its intensity 
profile across the yellow arrow.  (c) Quantification of percentage of extracellular 
parasites displaying cortical GAPDH1 localization in the genetically complemented 
GAPDH1cKD line as indicated for	   the	   mutant	   lines	   and	   in three independent 
experiments for	  the	  WT	  as	  shown	  in	  Figure	  3.7.	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Figure 4.3. Cortical translocation is not effected by phosphomutants 
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Figure 4.4. GAPDH1 enzymatic activity is significantly disrupted by constitutive 
S203 phosphorylation 
 
(a) GAPDH1 activity of the phospho-mutants as indicated measured after 60 hrs ± ATc.  
N=3 ± s.e.m. t-test, **P < 0.04. (b) Western blot indicating the level of myc2-GAPDH1 
protein in the GAPDH1WT and mutant complemented strains by α-human GAPDH and α-
myc antisera. α-IMC1 is used as a loading control.  
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Figure 4.4. GAPDH1 enzymatic activity is significantly disrupted by constitutive 
S203 phosphorylation 
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CHAPTER 5: TOXOPLASMA GAPDH1 ASSOCIATES TO THE MEMBRANE BY 
PALMITOYLATION 
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5.1. Introduction 
 
Toxoplasma GAPDH1 localizes to the cytosol of intracellular parasites, but is 
translocated (along with other glycolytic enzymes such as aldolase and lactate 
dehydrogenase) to the cortical membrane skeleton upon egression from the host cell 
(Pomel et al., 2008). This association is reversible as upon invasion GAPDH1 is swiftly 
released into the cytosol. The pellicle of Toxoplasma and other apicomplexan parasites is 
a unique and stable cellular architecture composed of plasma membrane, actinomysosin, 
and a quilt of flattened vesicles undergirded by microtubules and intermediate filaments 
that is termed the inner membrane complex (IMC) (Anderson-White et al., 2012). 
Cortical translocation of the glycolytic enzymes is postulated to enhance ATP delivery 
for active membrane transport and to power the motility apparatus in Toxoplasma (Pomel 
et al., 2008). The specific signal and mechanism of cortical skeletal association of 
GAPDH1 and other glycolytic proteins in the extracellular parasites has not been 
identified.  
 During Plasmodium falciparum schizogony, GAPDH associates with the plasma 
membrane of the schizont. The membrane association of Plasmodium GAPDH has been 
shown to rely on an interaction of the GAPDH N-terminus with Rab2 in an in vitro 
heterologous system employing human Rab2 and rabbit microsomes (Daubenberger et 
al., 2003). For the orthologous interaction between GAPDH and Rab2 in humans for the 
retrograde transport of Rab2-vesciles to the endoplasmic reticulum (Daubenberger et al., 
2003), phosphorylation of GAPDH on Tyr41 by Src kinase is required (Tisdale and 
Artalejo, 2007). This Tyr residue is positionally conserved in Toxoplasma GAPDH1 
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indicating this could be a potential mechanism underlying cortical membrane skeleton 
association.   
 An alternative or concurrent mechanism could be that association of GAPDH1 
with the membrane skeleton is mediated by reversible acylation: palmitoylation is a 
reversible modification that enables target proteins to associate with membranes. This 
modification involves the enzymatic attachment of a fatty acid (i.e. palmitic acid) to a 
sulfhydryl group on a protein, i.e. cysteine residues. Notably, a family of Toxoplasma 
palmitoyltransferases was recently reported and some of these enzymes do indeed reside 
in the IMC (Frenal et al., 2014a), and moreover, membrane association by palmitoylation 
has been demonstrated for other proteins residing in the membrane skeleton (Beck et al., 
2010; Garrison et al., 2012). Toxoplasma GAPDH1 contains several cysteine residues 
that could be palmitoylated. We considered the role of these modifications in 
understanding the mechanism of GAPDH1 translocation in the extracellular parasites. 
Our studies show that Cys3 residue is not critical for viability of the parasites but is 
essential for relocation (Dubey et al., 2016). 
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5.2. Results 
5.2.1. GAPDH1 translocation is not mediated by tyrosine phosphorylation 
Tyr41 is conserved in Toxoplasma GAPDH1 and is located in a surface helix α2 (Figure 
5.1. a). This residue can interact with the S-loop of the adjacent R dyad monomer; Tyr41 
of the R subunit can form hydrogen bonds with Gly190 and Ser192 of S the loop in the O 
subunit (Figure 5.1. b). Tyr41 is phosphorylated in human GAPDH (Tisdale et al., 2004), 
but accessibility for kinase and Rab2 may be hindered sterically by the apicomplexan 
dipeptide insertion (DI) in the S-Loop (Figure 5.1. c-d). Phosphomimetic (Y41E) and 
phosphonull (Y41F) alleles were generated and in the GAPDH1cKD background to 
examine whether Tyr41 phosphorylation is involved in GAPDH1 translocation to the 
cortical membrane skeleton (Dubey et al., 2016). Neither allele alters cortical 
translocation (Figure 5.3. b) and thus negates the hypothesis that Y41 regulates GAPDH1 
translocation to cortical membrane skeleton. Furthermore, both alleles support viability of 
the parasite as assessed by plaque assay (Figure 5.2. a), although we observe a nearly 4-
fold reduction in plaque size for the Y41E allele (Figure 5.2. b). Reduction in plaque size 
is likely due to a dramatic reduction in GAPDH1 catalytic activity (Figure 5.3. a) by 
altering the dynamic S-loop (Dubey et al., 2016).  
 
5.2.2. GAPDH1 is predicted to be palmitoylated 
Next we considered the putative role of palmitoylation in membrane skeleton 
translocation. To identify putative palmitoylation sites we first subjected Toxoplasma 
GAPDH1 to a bioinformatics prediction of palmitoylation sites using CSS Palm (Ren et 
al., 2008). We identified two putative palmitoylation sites; Cys3, which is unique to 
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Toxoplasma and other coccidians like Neospora, Eimeria etc., (Figure 5.4. a) and 
Cys249, which is widely conserved and also found in human GAPDH (Yang et al., 2005) 
(Figure 3.1).  The crystallographic structure of GAPDH1 indicates that Cys249 is not 
surface exposed in the GAPDH1 tetramer and its modification would block 
multimerization and thus enzymatic activity. However, Cys3 is surface exposed (Figure 
5.4. b). We studied the role of Cys3 in cortical membrane skeleton association by 
replacement with Ser in a GAPDH1 allele fused at the N-terminus to a tandem Myc. This 
allele was used for genetic complementation of the GAPDH1cKD line as described in 
chapter 3. These complemented mutants were tested by Dr. Matt Bogyo’s lab at Stanford 
to obtain direct proof of GAPDH1 palmitoylation using a chemically manipulatable 
palmitate mimic, 17- octadecynoic acid (17-ODYA) (Martin and Cravatt, 2009). In case 
C249 would be palmitoylated, we also generated a C249S mutant parasite line so we can 
discern it from C3S palmitoylation. From these data, we observe strong signals for wild 
type, C3S and C249S mutants  (Figure 5.5.) suggesting the presence of multiple sites of 
modification in GAPDH1 (Dubey et al., 2016). The observed signal was insensitive to 
hydroxylamine treatment suggesting that the modification does not occur on a cysteine 
residue. 17-ODYA can also detect O-palmitoylation (Zou et al., 2011), N-palmitoylation 
(Linder and Deschenes, 2007) as well as other post translational modifications such as 
GPI anchors (Binder et al., 2008), which are insensitive to hydroxylamine. These results 
therefore do not allow a conclusive assessment of whether C3 is palmitoylated in 
Toxoplasma. 
 
5.2.3. Palmitoylation is critical for translocation but not activity or viability 
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To assess the role of GAPDH1C3S in the parasite, we tested the viability of the 
complemented mutant line by plaque assay. We observed that loss of Cys3 
palmitoylation capacity has no effect on the lytic cycle (Figure 5.6. a). Next we tested the 
GAPDH activity in the parasites, which was not affected by the C3S mutation (Figure 
5.6. b). Subsequently we tested translocation and observed that Myc2-GAPDHWT is 
efficiently targeted to the cortical skeleton in extracellular parasites, however this 
association is reduced by 80% in Myc2-GAPDH1C3S expressing parasites (Figure 5.7. a). 
Thus, C3S is critical for efficient membrane skeleton association.  
 To consolidate the observation that Cys3 is critical for membrane association we 
directly determined the fractions of WT and C3S mutants associated with membrane 
through differential centrifugation and detergent extractions as shown in the schematic  
(Figure 5.7. b). Following osmotic and mechanical lysis of extracellular parasites in 
presence of minimal salt (5 mM) and low speed centrifugation, we observed slightly 
more material in the supernatant (S1) than in the pellet fractions (P1) for both WT and 
C3S parasites (Figure 5.7. c, d). This is somewhat unexpected since only non-lysed 
parasites and the cytoskeleton were expected to pellet. Probing for the cytoplasmic 
proteins actin (majority cytoplasmic) and CDPK1 (100% cytoplasmic) demonstrated that 
lysis was complete (Figure 5.7. d), thus suggesting that GAPDH1 associates with the 
cytoskeleton IMC1 (Figure 5.7. d). Alternatively, we considered that the membrane 
skeleton and even plasma membrane could remain associated with the cytoskeleton. 
Therefore we assessed how plasma membrane (SAG1, GPI-anchored (Burg et al., 1988)) 
and IMC membrane (ISP2, palmitoylated (Beck et al., 2010)) fractionated. Like 
GAPDH1, roughly half SAG1 ends up in the pellet (P1) whereas 100% of ISP2 is in the 
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pellet (P1) suggesting that half of the plasma membrane and all of the IMC membrane 
tightly associates with the cytoskeleton upon osmotic and mechanical parasite disruption. 
This complicates the analysis of membrane association. 
 Next we subjected the low-speed supernatant (S1) to high-speed centrifugation to 
pellet (P2) all membrane-associated proteins (Taha et al., 2014). While GAPDH1WT 
resides in the supernatant, suggesting this is mostly cytoplasmic, a significant fraction of 
GAPDH1C3S fractionates in the pellet, suggesting membrane association (Figure 5.7. c), 
Since, the majority of the membrane fraction of interest is present in the low-speed pellet, 
we further deciphered the state of membrane associated proteins in the low speed pellet 
fraction. We resuspended the pellet in a physiological buffer (150 mM NaCl) and first 
performed a high-speed spin to release proteins that interact mostly through electrostatic 
interactions rather than through lipid membrane anchoring. GAPDH1WT remains in the 
pellet (P3) whereas nearly half of GAPDH1C3S becomes soluble (S3) (Figure 5.7. c). This 
suggests that the association of GAPDH1C3S with the membrane/cytoskeleton is based 
largely on electrostatic interactions.   
 Subsequently we assessed whether we could remove GAPDH1 from the low 
speed pellet (P1) by detergents. As expected, treatment with 1% SDS solubilizes all 
proteins probed (Figure 5.7. d S4 and P4). In the control, where no detergent was added 
C3S again stood out by its significant release from the P1 fraction (Figure 5.7. d S7 and 
P7). We observed no major difference from the wild type construct using mild detergents 
(Figure 5.7. d, TX-100 and NP-40). As expected, both membrane-associated proteins 
SAG1 and ISP2 solubilized with mild detergent whereas the cytoskeletal protein IMC1 
did not, which demonstrates that our assay works well. In conclusion, the interpretation 
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of Toxoplasma membrane fractionation is complicated by strong association between the 
cytoskeleton and membrane structure of interest, but our results are consistent with a 
critical role for Cys3 in membrane association, potentially through palmitoylation (Dubey 
et al., 2016).  
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5.3. Discussion 
Tyr41 is conserved in GAPDH of most eukaryotes, with the noted exception of a 
histidine replacement in Plasmodium GAPDH. Whether Tyr phosphorylation is 
physiologically relevant in Toxoplasma is questioned by the absence of conventional Tyr 
kinases from the genome (Peixoto L, 2010), although the Toxoplasma phosphoproteome 
contains Tyr phosphorylation events (Treeck et al., 2011b). This study does not support 
the hypothesis that cortical translocation of Toxoplasma GAPDH1 is due to Tyr41 
phosphorylation and interaction with Rab2 to mediate vesicular trafficking along dynein-
powered microtubules as inferred from human GAPDH (Tisdale et al., 2004; Tristan et 
al., 2011). Tyr41 is replaced by phosphorylatable histidine in Plasmodium GAPDH and 
His41 phosphorylation is not detected in the available Plasmodium phosphoproteome 
(Treeck et al., 2011b). Further investigation is required to examine Toxoplasma and 
Plasmodium GAPDH phosphorylation and how it relates to Rab2 interaction 
(Daubenberger et al., 2003). Nonetheless, molecular disruption of Tyr41 in Toxoplasma 
GAPDH1 alters the dynamic S loop and the primary role of glycolysis. 
 Both IFA fractionation data strongly implicate Cys3 in membrane skeleton 
association thereby uncovering a novel GAPDH membrane association mechanism 
besides the two known mechanisms of GAPDH association through Rab2 association or 
spectrin-actin association (Tisdale et al., 2004; Waingeh et al., 2006). IMC association is 
mediated by Cys3 residue of GAPDH1. Since translocation of the GAPDH1C3S allele is 
not completely abolished we are not sure whether GAPDH1 is still able to translocate to 
some extent by association with glycolytic enzyme complex (Aldrich et al., 1992; 
Campanella et al., 2005a). Additional mechanisms of cortical membrane skeletal 
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association may include the PSB domain and secondary palmitoylation at Cys249 of 
GAPDH1, although palmitoylation at this site would prevent catalytic activity since it is 
incompatible with protein multimerization.  
 Our attempt to validate the predicted palmitoylation of C3 residue by 17-ODYA 
labeling was not successful. Though we are able to show that 17-ODYA modifies 
GAPDH1, the modification is insensitive to hydroxylamine, suggesting there are residues 
other than the predicted C3 and C249 that may be palmitoylated and likely not mediated 
through thio-ester modification.  Bioinformatics predictions of other lipid modifications 
using online tools such as GPS lipid and NMT predictor (myristoylation, prenylation, 
farnesylation) were also done but did not yield any significant hit. Hence, our data reveal 
a complex modification picture preventing the direct assessment of whether C3S is 
palmitoylated.  
  Data from this study also suggest that cortical translocation of GAPDH1 is not 
essential for parasite viability. It has been shown that after prolonged extracellular gliding 
stored ATP becomes depleted (MacRae et al., 2012) and it is therefore feasible that local 
ATP production at the cortex becomes much more critical in such situation. 
Alternatively, although our data demonstrate balanced expression of endogenous and 
complemented GAPDH1 alleles, it is possible that the spurious general cytoplasmic 
localization of GAPDH1 as a result of overexpression is able to overcome specific 
membrane association, as has been shown for the CDPK3 kinase anchored in the IMC 
(Garrison et al., 2012). No effect of palmitoylation mutants is observed on GAPDH 
activity of the parasites. Overall, our data suggest that cortical translocation is decoupled 
from glycolytic essentiality.  
110	  	  
Figure 5.1. Tyrosine phosphorylation in the S loop may be sterically hindered  
 
a) Surface rendering of Toxoplasma GAPDH1 tetramer illustrating the interaction of 
Tyr41 to S-Loop of neighboring subunit. (b) Tyr41 (red) of R subunit forms 3 hydrogen 
bonds with Gly190 and Ser192 of the S loop in the O subunit. (c) Apicomplexan 
dipeptide insertion (DI) in the S-Loop may sterically hinder accessibility for kinase and 
Rab2. (d) The dipeptide exhibits a positive surface charge as determined by surface 
electrostatic potential analysis where positively charged residue is rendered as blue and 
negative charged is red. Attachment to membrane by the predicted PSB patch (magenta) 
may interfere with access to the S loop and catalytic pocket.  
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Figure 5.1. Tyrosine phosphorylation in the S loop may be sterically hindered  
 
 
 
  
112	  	  
Figure 5.2. Phosphomimic Tyr41 affects parasite lytic cycle 
 
(a) Ten day plaque assay for genetically complemented Y41E and Y41F mutants of 
GAPDH1cKD. (b) Quantification of plaque size of the mutants was obtained by 
measuring plaque area of 30 plaques as indicated after 10 days ± ATc. N=3 ± s.e.m. t-test 
**P < 0.02.  
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Figure 5.2. Phosphomimic Tyr41 affects parasite lytic cycle 
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Figure 5.3. Potential tyrosine phosphorylation of the S loop modulates GAPDH 
activity  
 
(a) GAPDH activity of the phospho-mutants as indicated measured after 60 hours ± ATc. 
N=3 ± s.e.m. t-test, **P < 0.02. (b) Percentage of extracellular parasites displaying 
cortical GAPDH1 localization of the genetically complemented GAPDH1cKD parasites 
as indicated was obtained by counting more than 200 parasites. N=3 ± S.D.  
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Figure 5.3. Potential tyrosine phosphorylation of the S loop modulates GAPDH 
activity  
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Figure 5.4. GAPDH1 is predicted to be palmitoylated 
 
(a) GAPDH1 sequence alignment of related coccidian parasites with the conserved Cys3 
residue highlighted in yellow. (b) Crystallographic structure reveals that the N- and C-
termini ends at surface cleft in which the predicted palmitoylation of C3 (red) is surface 
accessible. This residue is located near the N-terminus of beta-sheet 1. (c) Cys3 is 
positioned at the edge of the PSB patch. (d) Surface electrostatic potential rendering 
shows that palmitoylated residue lies in a positive surface patch that may facilitate 
protein-protein interaction.  
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Figure 5.4.  GAPDH1 is predicted to be palmitoylated 
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Figure 5.5. 17ODYA labeling to analyze GAPDH1 palmitoylation  
 
Top panel: Rhodamine fluorescence scan of IP optionally followed by hydroxylamine 
treatment (-/+).  Bottom panel: western blot with α−myc as a loading control. IP was 
done as described in the methods section (Dubey et al., 2016) using the following strains 
parental line Δku80, complemented lines expressing either GAPDH1WT or mutants in the 
predicted palmitoylation sites, GAPDH1C3S and GAPDH1C249S.  
  
119	  	  
Figure 5.5. 17ODYA labeling to analyze GAPDH1 palmitoylation  
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Figure 5.6. The C3S palmitoylation mutant has no effect on viability or activity 
 
(a) Plaque assay of parasites expressing N-terminally-Myc2 tagged GAPDH1C3S variant 
after 9 days incubation stained with crystal violet. (b) GAPDH activity expressed in 
GAPDH units in complemented strains after 60 hrs ± ATc. N-terminally-tagged 
mCherryRFP Toxoplasma GAPDH1WT where GAPDH1 translocation is blocked is used 
as a control for activity assay here.   
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Figure 5.6.  The C3S palmitoylation mutant has no effect on viability or activity 
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Figure 5.7.  GAPDH1 Cys3 is critical for translocation 
 
(a) Cortical translocation of N-terminally Myc2 tagged GAPDH1WT and a GAPDH1C3S 
variant was quantified by counting more than 200 parasites in the extracellular stage. N=3 
± S.D.  t-test,  ***P < 0.0003. Most representative image probed using α-Myc (green) for 
GAPDH1WT and mutant GAPDH1C3S corresponding to the bars in the graph is shown 
below. (b) Flowchart of fractionation and detergent extraction experiment. (c) Western 
blots of GAPDH1WT and GAPDH1C3S strains after the low speed and high speed spins. 
The membrane was probed with α-Myc. (d) Detergent extractions of GAPDH1WT and 
GAPDH1C3S strains using the indicated conditions followed by probing with α-Myc. 
Samples were probed with the following controls: α-IMC1 (cytoskeleton), α-CDPK1 
(cytosolic), α-ACT1 (cytosolic), α-SAG1 (plasma membrane) and α-ISP1 (IMC 
membrane bound through myristoylation and palmitoylation). 
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Figure 5.7. GAPDH1 Cys3 is critical for translocation 
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CHAPTER 6: CONCLUSIONS AND FUTURE DIRECTIONS 
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6.1. Conclusions 
Many cortical cytoskeleton building blocks have been identified over the last 
decade in Toxoplasma; however, very few components have been functionally 
characterized. In the first part of this study, a group of three related intermediate filament-
like proteins localizing to the IMC of mature parasites has been studied in detail. I 
defined the spatio-temporal association of IMC7, 12 and 14 to the cortex of the parasite 
as occurring in the mid and late G1 phase of the cell cycle. These IMC proteins relocate 
to the cortex before entering S-phase and distinctly mark the mother cytoskeleton from 
the forming daughters. Although one of our working models was that this could 
differentially stabilize mother and daughter cytoskeletons through the final steps of cell 
division when the mother disassembles, KO studies did not support this model. The 
alternative model of providing tensile strength to the parasite in the extracellular 
environment was better supported by the experimental data for IMC7 and IMC14, but not 
IMC12. Furthermore, we determined that only IMC14 disrupts the synchronous cell 
division of the parasites but IMC7 and 12 have no effect. This indicates a unique function 
of IMC14 and may signify a special role in conjunction probably with some other IMC 
proteins like IMC15, the first cytoskeletal component of budding (Anderson-White et al., 
2011) to maintain the timing of budding daughter cells. In absence of IMC14 the parasite 
begins to enter next nuclear cycle, as the regulated control of the inner and outer core of 
the centrosome appears to be disrupted leading to a new mitotic cycle before the 
completion of cytokinesis.   
Though we have not established the mechanism of cortical translocation for the 
IMC proteins, in the case of IMC12 it may be regulated by calcium dependent 
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phosphorylation in the extracellular stage, as this is the only protein where we observe 
increasing translocation during increasing time spend outside the host cell.  It is also the 
only protein wherein calcium dependent phosphorylation associated with egress is 
observed (Nebl et al., 2011). Additionally, phosphoproteome of the peptides enriched 
from intracellular and extracellular tachyzoites reveal calcium independent 
phosphorylation sites in IMC7, 12 and 14. These sites may be involved in the 
translocation of IMC proteins from mid G1 to late G1, but the phosphoproteome data is 
not resolved through the lytic cycle and does not permit a direct functional association 
(Treeck et al., 2011a). Only IMC14 is predicted to be palmitoylated but not IMC7 or 12 
so this may have some role in IMC14 translocation.  
Additionally, our data showed that all three IMC proteins are dispensable for the 
lytic cycle. It is possible that these proteins are functionally redundant in the parasite and 
a phenotype, even in differential mother-daughter stability, would only become 
appreciated upon double or triple gene knockouts. Alternatively, these IMC proteins may 
be forming oligomers through their conserved alveolin domains and being carried to the 
cortex in a complex. 
 Membrane skeletons are commonly found in free living protozoans for 
maintaining the cell shape and providing mechanical stability, like tetrins in Tetrahymena 
(Brimmer and Weber, 2000), epiplasmins in Paramecium (Pomel et al., 2006) and 
articulins in euglenoids (Marrs and Bouck, 1992) and ciliates (Huttenlauch et al., 1998).  
Additionally, it is seen that bacteria like Caulobacter crescentus rely on intermediate 
filament based cytoskeleton for its cell shape. Moreover, in Plasmodium IMC proteins 
function in morphogenesis accompanied by reduced tensile strength of the zoites (Tremp 
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et al., 2008). However, it is important to note that in Toxoplasma the IMC genes 
expressed is not life cycle specific unlike Plasmodium where select alveolin family 
members are expressed at different life cycle stages such as sporozoite, merozoite, 
ookinete and gametocytes (Kono et al., 2012; Tremp et al., 2014). So even though the 
IMC 7, 12 and 14 are not required for the lytic cycle they may have critical roles in 
merogony, sporogony or gamogony.   
The cross disciplinary work spanning parasite molecular biology, biochemistry, 
cell biology and structural biology in the later part of the thesis gives a comprehensive 
overview of the role of GAPDH1 in Toxoplasma (Dubey et al., 2016). We showed that 
GAPDH1 is essential for the parasite and that the parasites die within the parasitophorous 
vacuole between 60 and 84 hours following knockdown of GAPDH1 expression. In 
addition, we showed that GAPDH1 is not required for invasion or egress (Figure 3.6.) 
whereas the morphology of parasites without GAPDH1 also did not change (Figure 3.5. 
c). We concluded that GAPDH1 is required for intracellular growth.  
We were able to rescue the viability of the parasite by complementing the 
GAPDH1cKD with wild type GAPDH1 fused to either a small or large tag. Large tags 
block the phenomenon of relocation of GAPDH1 from the cytosol to the cortex upon 
parasite egress but not the complementation capacity indicating that translocation of this 
glycolytic enzyme is dispensable for the parasite. It could however also be that the 
overexpression of these constructs can complement the phenotype and support viability 
likely by also increasing the cortical presence of GAPDH1 as shown for CDPK3 
(Garrison et al., 2012). Support for this latter model comes from the high GAPDH 
activity measured in the complemented strains relative to the wild type line, despite a 
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fairly balanced protein expression level. We attempted to correct this imbalance by 
targeting GAPDH1 as a single copy in the UPRT locus or by genetic complementation 
under the endogenous promoter rather than the strong α-tubulin promoter, but these 
experiments yielded similar results. Alternatively, it is possible that the tag might drive 
high enzymatic activity, but we did not make an effort to complement the cKD line with 
an untagged allele, as we would not be able to distinguish endogenous GAPDH1 from 
complementing GAPDH1 protein. 
 The catalytic activity of GAPDH1 is controlled by the conserved active site 
residue C152. Mutating this residue completely blocks GAPDH activity in the parasite 
and also disrupts ATP production. This mutant relocates to the cortex but is unable to 
restore the viability of the cKD line. Additional experiments to rescue viability of the 
active site mutants with glutamine supplementation (Shen and Sibley, 2014) restored 
growth to about 50%. In parasites without ALD1, an accumulation of toxic levels of 
fructose-1-phosphate in presence of glucose was reported that caused parasite death. This 
effect was alleviated when the parasites were able to salvage energy from glutamine 
(Shen and Sibley, 2014). We on the other hand did not observe a disruption in replication 
in presence of glucose, indicating that no accumulation of toxic metabolite occurs, which 
further indicates that glucose is preferred over L-glutamine as carbon and energy source 
for the parasite (Figure. 3.11. a-b).  
The mechanism of glycolytic enzyme translocation in extracellular parasites was 
unknown (Pomel et al., 2008). The data presented in this thesis established that 
translocation is conferred most likely by N-terminal palmitoylation of GAPDH1. We 
observed that GAPDH1 is palmitoylated and that at least some mode of the modifications 
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detected by 17-ODYA are not hydroxylamine sensitive. This prevents a direct conclusion 
toward the palmitoylation of Cys3/Cys249. Using the crystal structure information of 
TgGAPDH1 and our mutagenesis experiments we know that Cys3 residue is an important 
residue governing GAPDH1 association with the cortical membrane skeleton of parasite. 
Our palmitoylation mutants showed significant reduction in translocation as verified by 
both IFA and fractionation experiments.  It is important to note that ALD1 and LDH1 are 
also predicted to be palmitoylated at several cysteine residues indicating that there may 
be a common mechanism for translocation of these glycolytic enzymes.  
Our data showed that Tyr41 phosphorylation mediating Rab2-dependent cortical 
translocation as suggested in Plasmodium (Daubenberger et al., 2003) does not contribute 
to GAPDH1 translocation in Toxoplasma. Moreover, the timing is different as 
PfGAPDH1 translocates during the intracellular replication cycle. Since PfGAPGH1 does 
not contain a Cys at position 3 and has no IMC during schizogony, it is therefore 
conceivable that both the function and mechanism of cortical translocation is different 
between Plasmodium and Toxoplasma GAPDH1.  
 Our data combined with our knowledge about the TgGAPDH1 structure and 
phosphoproteome of Toxoplasma identified a distinct role for post-translational 
phosphorylation of the GAPDH1 S-loop. The phosphorylation of the Ser50 residue at the 
dimer interface of the GAPDH1 offers a novel mechanism of allosteric regulation of 
protein assembly indicated by their inability to support growth not previously reported. 
Additionally, another unique residue S203 in the parasite is positioned in the S-loop and 
is involved in enzyme catalysis. Moreover, Y41 mimics in the S-loop also resulted in a 
significant reduction in activity. This further underscores the essentiality of the S-loop in 
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activity, even though this modification may not be physiologically relevant due to the 
absence of tyrosine kinases in Toxoplasma (Peixoto L, 2010). This is the first report of S-
loop phosphorylation regulating catalytic function of GAPDH, which may be more 
universally conserved as Ser50 is conserved across GAPDH evolution.  
GAPDH1 is likely to be essential in vivo because human serum has high level of 
glucose that would block the growth of GAPDH1 depleted parasite and also the non-
enzymatic roles of GAPDH1 cannot be fulfilled by glutamine supplementation. Our data 
therefore suggests that GAPDH1 can be a good drug target by directly targeting 
GAPDH1 activity. Moreover, to our best knowledge regulation of activity by S-loop 
phosphorylation is absent from the mammalian host; hence drugs targeting the 
Toxoplasma kinase(s) responsible for S-loop phosphorylation might provide specific new 
drugs. Also, TgGAPDH1 along with its apicomplexan members have a unique dipeptide 
insertion in the S-loop that constricts the opening of NAD+ cavity compared to human 
GAPDH (Satchell et al., 2005). Inhibitors can be designed to target this bulge of the S-
loop and hence activity. Such drug leads are also very relevant for other apicomplexan 
parasites, including the major childhood diarrhea-causing Cryptosporidium and the 
malaria-causing Plasmodium spp. for which very limited effective drug options are 
available.	  	  
 In summary, the work presented in this thesis shows uncoupling of GAPDH1 
functions at both the biological and mechanistic level: glycolysis is essential for 
replication and mediated by the buried core center and is regulated by the S-loop 
phosphorylation whereas cortical membrane association occurs in extracellular parasites 
and is facilitated by palmitoylation at the surface exposed N-terminus.  
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6.2. Future Directions  
To completely understand the functional role of IMC protein cortical association after 
complete division we need to generate multiple gene knockout lines. With the advent of 
CRISPR, this is not a very challenging task and we can create a series of double or even 
triple knockout lines of IMC7, 12 and 14 together to resolve the functional redundancy in 
the parasite, if any. IMC7 and IMC14 are both involved in maintaining the tensile 
strength of the parasite. Since we have a conditional knockdown line of IMC7, we can 
create a direct KO line of IMC14 in that background and decipher if the absence of these 
proteins incurs severe defects on the lytic cycle of the parasite or whether the tensile 
strength is more essential in other stages of life cycle. Since IMC7 and IMC12 expression 
peaks at mid G1 stage, it is possible these are functionally redundant for asexual 
replication of the parasite. We can further attempt to create a triple knockout of all these 
proteins since they are exclusively associated with the mother cytoskeleton or use a 
conditional knock out system using the cre-lox system in case the complete knockout is 
essential. There is also a possibility that these proteins are not essential in the lytic cycle 
of the parasite and we will have to further probe their role in merogony, gametogony or 
sporogony. Since we have already established that these IMC proteins relocate from the 
cytosol to the cortex completely by late G1 stage and are maintained to the cortex in the 
extracellular stage, it will be interesting to establish the mechanism of the translocation of 
IMC proteins. IMC14 is predicted to be palmitoyalted like GAPDH1 where translocation 
is guided by palmitoylation at the N-terminus. However, IMC12 is known to be 
phosphorylated both in calcium dependent and independent manner by yet unidentified 
protein kinases (Nebl et al., 2011; Treeck et al., 2011b) so we can hypothesize that this 
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phosphorylation may play a critical role in the process. Our initial attempts to 
complement the IMC12 dKO line with calcium dependent phosphomutants were not 
successful due to low transfection efficiency making interpretation of data difficult and 
inconclusive. Generation of clonal lines and quantifying the phosphonull and 
phosphomimic lines for translocation phenotype can establish if the mechanism is indeed 
based on this modification. However, it may be that there is a dominant negative effect 
due to which we were not able to get any stable lines. This can be overcome by 
conditionally expressing the mutants in the knockout line. Additionally, it could also be 
possible that IMC12 helps to relocate IMC7 and IMC14 to the cortex by forming a 
complex.  
 GAPDH is ubiquitous and is increasingly known for its role in multiple pathways 
including membrane fusion, microtubule bundling, phosphotransferase activity, nuclear 
RNA export, DNA replication and DNA repair (Du et al., 2007; Kim et al., 1999; 
Sirover, 1999), in addition to glycolysis. It will be interesting to establish other 
moonlighting roles of GAPDH1 in the parasite. GAPDH controls apoptosis in vertebrates 
via lysine acetylation (Hara et al., 2005; Sen et al., 2008) however; we were not able to 
detect this phenomenon in Toxoplasma upon lysine mutation (Dubey et al., 2016).  
It is possible that one of these glycolytic enzymes directly interacts with the 
cortex and others are bound via them to the membrane. We did observe electrostatic 
interactions in our fractionation experiments (Figure 5.7, section 5.2.3) indicating 
protein-protein interaction. The glycolytic enzymes complex would require labile 
cofactors or depend on low affinity interactions and such physical association of these 
enzymes would allow for true substrate channeling and hence efficient ATP production 
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(Pomel et al., 2008).  So we can ascertain if this close association of the glycolytic 
enzyme to the pellicle of the parasite can markedly improve the overall efficiency of local 
ATP production. GAPDH1 is present on the cytosolic phase of IMC which is probably 
tethered to the IMC via the glideosome associated proteins GAP40, GAP45 and GAP50 
embedded in the opposing membrane by palmitoylation and myristoylation. Missing in 
this model however, is a channel through the IMC permitting the transport of ATP but the 
GAPM proteins might be candidates for this function (Bullen et al., 2009).  Since the 
parasites do not require carbon uptake in the first hour of its extracellular life so doing a 
time point study of extracellular incubation followed by invasion assay could establish if 
relocation occurs essentially for efficient generation of energy at the site of requirement. 
Additionally, it will be interesting to explore if GAPDH1 may have a novel moonlighting 
function in providing resistance to the parasite under osmotic stress like the IMC proteins 
that are involved in maintaining tensile strength of the extracellular parasite.  
From a drug development perspective, identifying the kinases phosphorylating the 
S-loop should be a priority toward the designing of specific inhibitors whereas other 
inhibitors might be designed targeting the constricted NAD+ pocket of enzyme due to 
dipeptide insertion.   
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CHAPTER 7: MATERIAL AND METHODS 
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7.1. Parasites  
RH, RHΔku80 (Huynh and Carruthers, 2009) and TATiΔku80 (Sheiner et al., 2011) 
parasites and their transgenic derivatives were used in this study. All strains were 
maintained in human foreskin fibroblasts (HFF) as previously described (Roos et al., 
1994). All parasites were grown at 37°C and 5% CO2 except the temperature sensitive 
mutant FV-P6 which was cultured at 35°C permissive temperature or 40°C restrictive 
conditions. Stable parasite lines expressing transgenes were selected under 20 µM 
chloramphenicol or 1 µM pyrimethamine based on the resistance marker and cloned by 
limiting dilution.   
  Specifically, IMC7 (conditional knockdown) cKD, IMC12 and IMC14 direct 
knockout (dKO) and GAPDH1 (cKD) were generated by double homologous 
recombination under pyrimethamine selection for the purpose of this study. Other 
parasite lines stably expressing complementing transgenes or GAPDH mutations were 
selected in presence of chloramphenicol. The cKD lines were induced at a concentration 
of 1.0 µg/ml anhydrous tetracycline (ATc) for the times specified.  
    
7.2. Plasmids  
All primer sequences can be accessed in the Table 6.1. The plasmid ptub-myc2-
GAPDH1/sagCAT, ptub-YFP-GAPDH1/sagCAT and ptub-mCherry-GAPDH1/sagCAT 
were generated by amplifying the GAPDH1 coding sequence using primers #1 and #2  
(GAPDH primers section). The insert, digested with AvrII/EcoRV, was cloned into the 
ptub-YFP2 (MCS)/sagCAT plasmid (Anderson-White et al., 2011). 
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Three-way Gateway cloning (Invitrogen) was employed to generate the IMC7 and 
GAPDH1 conditional knockdown vector; basically following published protocols (Farrell 
and Gubbels, 2014). Specifically, the RH genomic DNA was used as a template to 
amplify the region upstream of the promoter region and beginning of the start codon of 
the two genes of interest (goi). The entry clone plasmid pDONR221-goi-R1/R4 was 
generated by amplifying approximately 1 kb upstream of the promoter region (1.5 kb 
upstream of start codon) into the pDONR221 P1/P4 plasmid. The entry clone plasmid 
pDONR221-goi-R3/R2 was generated by amplifying a region upstream of the promoter 
region of the gene and cloned into the pDONR221 P3/P2 plasmid. The conditional 
knockout vector pTgKO2-DHFR-T7S4-goi was generated by combining the pTgKO2, 
pDONR221-5’goi-R1/R4, pDONR221-DHFR-T7S4 R4/R3 and pDONR221-goi R3/R2 
plasmid in an LR reaction. The plasmid pTgKO2-DHFR-T7S4-GAPDH1 was linearized 
with unique restriction enzyme AflII and pTgKO2-DHFR-T7S4-IMC7 with ApaI prior to 
transfection into the TATi Δku80 strain. The stable lines were generated by 
pyrimethamine selection. 
 
The plasmids 5-pU6-IMC12 and 3-pU6-IMC12 to generate IMC12dKO line and the 
plasmids 5-pU6-IMC14 and 3-pU6-IMC14 to generate the IMC14dKO line were 
generated using previously published method. Specifically, sense and antisense 
protospacers were annealed by boiling them at 98°C for 5 mins in a beaker and slowly 
cooling by placing the beaker on ice for 2 hrs.  The pU6-Sag1 vector was digested with 
BsaI, dephosphorylated and purified. The purified vector and annealed protospacers are 
ligated to generate the pU6-goi. Sanger sequencing using the primer U6_sequence-F is 
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then used to verify the sequence of the protospacers in the purified plasmid. For the 
generation of the IMC12dKO strain the Δku80 line was transfected to with the 20 µg of 
5-pU6-IMC12 and 3-pU6-IMC12 plasmid pair alongwith 40 µg of the PCR product of 
DHFR locus (amplified from the pDHFR-teto7SAG4 vector) with homologous flanks to 
IMC12 using the primer pair #8/9 mentioned in Table 6.1 (IMC primers list). Similarly, 
to generate the IMC14dKO line 20 µg of 5-pU6-IMC14 and 3-pU6-IMC14 and 40 µg 
PCR product of DHFR locus with homologous flanks to IMC14 (#19/20 primer pairs) 
were transfected into the Δku80 parasite strain.  
 
Megaprimer mutagenesis was used to generate point mutations in IMC12 and GAPDH1 
as described (Gubbels et al., 2006). PCR products were TOPO-cloned, sequence-
validated by Sanger sequencing, and ligated into the ptub-YFP-IMC12/CAT or ptub-
myc2-GAPDH/CAT backbone to generate the YFP-IMC12 phosphomutants or the myc2 
tagged mutant GAPDH1 plasmid with desired mutation using the primers mentioned in 
Table 6.1. 50 µg of plasmid was transfected in the IMC12dKO or the GAPDH1cKD 
strain to generate the mutant lines under chloramphenicol selection.  
 
 
7.3. PCR verification of parasite genotypes and homologous recombination 
All primers used for verification of the integration of the mentioned plasmids in the 
parasite genome are listed in Table 6.1 split between IMCs and GAPDH1 group of 
primers. Proper insertion of the T7S4 replacing the gapdh1 promoter was done using the 
primer pairs 9/10 and 11/12, while the re-insertion was verified by 13/12 (from the 
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GAPDH primer list). Similarly, using the IMC primer list, the replacement of the imc7 
promoter was done using primer pairs 1/2 and 3/4.  The replacement of native promoter 
was tested using the primer pairs 5/12 and 13/6. To test the replacement of the complete 
locus of IMC12 gene by DHFR selectable marker 10/12 and 13/14 primer pairs were 
used. Additionally, the reinsertion of the genomic IMC12 was tested using the primer 
pair 15/16. Similarly, IMC14dKO line was tested for the replacement of the genomic 
locus with DHFR using pairs 21/12 and 13/22 while the primer pair 23/24 verified the 
absence of reinsertion. The GAPDH mutations in parasites clones expressing mutant 
GAPDH1 alleles were validated by PCR amplification of the cMyc-tagged allele and 
Sanger sequencing. 
 
7.4. Immunofluorescence 
Immunofluorescence assays were performed as previously described (Gubbels et al., 
2006). Parasite strains of choice were inoculated in six-well plates containing coverslips 
with HFF cells and fixed with 100% methanol and blocked in 1% BSA in PBS. 
Alternatively, extracellular parasites were adhered on coverslips coated with poly-Lysine 
for 1 hr at 37°C. The following primary antibodies were used: rat α-IMC3 (Anderson-
White et al., 2011) (1:2000), rat α-IMC7(Anderson-White et al., 2011) (1:2000), mouse 
MAb 45:36 α-IMC1 (1:1000; kindly provided by Gary Ward, University of Vermont), α-
Myc (9E10) conjugated with A488 (1:100; Cell Signaling) and rabbit α-human centrin 
(1:1000; kindly provided by Iain Cheeseman, Whitehead Institute). Alexa fluorophores 
A488 and A594 (Invitrogen) conjugated to goat-α-rat, goat-α-rabbit, and goat-α-mouse 
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secondary antibodies were used (1:400). Nuclear material was co-stained with DAPI (2 
µg/ml).  
 
7.5. Fluorescence microscopy 
For IFA and live cell microscopy a Zeiss Axiovert 200 M wide-field fluorescence 
microscope equipped with a α-Plan-Fluar 100X/1.45 NA oil objective and a Hamamatsu 
C4742-95 CCD camera was used to collect images, which were deconvolved and 
adjusted for phase-contrast using Volocity software (Improvision/Perkin Elmer). To 
capture images for the invasion assay an EVOS FS Cell Imaging System (Life 
Technologies) was used.  
 
7.6. Plaque assay 
Six-well plates confluent with HFF cells were inoculated with 50 freshly lysed parasite 
lines and incubated for 8-10 days ± ATc. Monolayers were fixed with 100% ethanol for 
10 min, washed with PBS and stained with crystal violet (Farrell and Gubbels, 2014). 
Plaques were counted and plaque area quantified using Fiji (Schindelin et al., 2012).  
 
7.7. Osmotic shock assay 
Freshly lysed dKO, cKD or parental lines were treated with hypotonic buffer (HBSS 
diluted to 0.5X or 0.25X in sterile water) as previously described (Harding et al., 2016). 
Specifically, the strains were filtered and spun at 1000g for 15 min followed by 1X PBS 
wash before subjecting them to osmotic shock for 5 min. 0.2% saponin was done as a 
positive control and 1M sorbitol treatment was done to maintain cell rigidity and 
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represent hypertonic stress condition. Post treatment the cells were stained with 1:200 dil 
of 488 conjugated Sag1 for 30 min on ice in dark. 1X PBS was done and stained parasites 
were spun at 1000g for 15 min at room temperature. The pelleted cells were resuspended 
in 1 mg/ml Propidium iodide (PI) for 10 min on ice. Unstained parasites were used as a 
control and FITC and PI positive cells were scanned by Flow cytometer.  
 
7.8. Growth assay  
Parasitic growth curve based on cytoplasmically expressed YFP-YFP in TATiΔku80 and 
GAPDH1cKD was recorded basically as described previously (Gubbels et al., 2003) by 
reading their relative fluorescence every 24 hrs using Molecular Dynamics M5 plate 
reader at 510 nm excitation and 540 nm emission wavelength using a 530 nm cut off. 
Stable cytoplasmic YFP-YFP overexpressing GAPDH1cKD lines were selected by two 
rounds of FACS and cloned by limiting dilution. Three independent experiments were 
done in triplicate using 5000-parasites/well ± ATc. 
 
7.9. Replication assay 
Parasite division in HFF infected with 1.8x105 par/well inoculated in a 6 well plate was 
measured in regular medium ± ATc via IFA using α-IMC3 and α-human centrin as 
development markers (Szatanek et al., 2012). More than 100 vacuoles per sample were 
counted in three independent experiments and expressed as average number of 
parasite/vacuole. Similarly, for assessing division in glutamine supplementation media 
(MacRae et al., 2012), HFF monolayer was infected with parasites, after washing with 
DMEM without glucose or glutamine (MacRae et al., 2012) and incubating for 2 hrs in 
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same media, to make them glucose starved. Also the parasites prior to infection were 
depleted of residual glucose. The ATc pretreated parasites were washed in DMEM 
without glucose containing 6 mM L-glutamine (MacRae et al., 2012) (or DMEM without 
glutamine containing 4.5 g/L glucose as control) and incubated at 37°C for 2 hrs. 1.8x105 
parasites per well were inoculated in a 6 well plate with the corresponding media ± ATc. 
Following 24 hrs of incubation, monolayers were fixed with 100% methanol and 
subjected to IFA using rat α-IMC3 and rabbit α-human centrin antibodies. More than 100 
vacuoles were counted in each experiment and values were expressed as cell division. 
 
7.10. Invasion assay 
The ‘Red-Green-Assay’ was done as described previously (Garrison et al., 2012). Briefly, 
2.5x105 parasites were allowed to invade in HH/FBS (Hank’s balanced salt solution, 1 
mM Hepes pH 7.0, 1% FBS) medium ± ATc in black well optical bottom 96 well plate in 
triplicate at 37°C for 1 hr. A488 conjugated mouse α-SAG1/P30 T41E5 (kind gift from 
J.F. Dubremetz, University of Montpellier) was used to stain all the parasites and post 
16% formaldehyde, 8% glutaraldehyde fixation and 0.25% Triton X-100 
permeabilization, A594 conjugated mouse α-SAG1/P30 T41E5 was used to stain all 
extracellular parasites. Three images per well were recorded using EVOS FS Cell 
Imaging System (Life Technologies) and more than 100 parasites were counted to 
determine percentage of invaded parasites using Fiji software (Schindelin et al., 2012). 
Parasites were treated with 1 µM Cytochalasin D for 15 min as positive control for the 
assay.  
7.11. Egress assay 
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Parasite egress from host cells was assayed as described previously (Garrison et al., 
2012). Essentially, 6 well plate-containing coverslips confluent with HFF cells were 
infected with 6x106 parasites ± ATc. 30-34 hrs post-inoculation, 2 µM of A23187 or 
DMSO vehicle control was used to trigger egress for 5 min at 37°C. Methanol fixation 
followed by Hemacolor (EMD Chemicals) staining was done as per manufacturer’s 
instructions and over 15 fields were counted for intact vacuoles in each set. 
 
7.12. SDS PAGE and Western blot 
Western blot was performed as previously described (Gubbels et al., 2006). Lysate from 
5x106 parasites was loaded in 12% Bis-Tris gel (Invitrogen), transferred to PVDF 
membrane (Bio-rad), blocked in 5% milk in 1X PBS + 0.1% Tween40 (PBS-T) and 
probed with one of the following primary antibodies, rabbit α-human GAPDH antibody 
conjugated with horse radish peroxidase (HRP) (TGR BioSciences), α-cMyc (9E10) 
conjugated with HRP (Santa Cruz Biotechnologies), α-IMC7, α-IMC1, α-CDPK1 
(1:1000), α-SAG1 (1:1000), α-ACT1 (1:2000) or α-ISP1 (1:1000). Following 1 hr 
incubation the membrane was washed 3 times with PBS-T for 10 min and probed with 
corresponding secondary antibody for 1 hr. Washing steps were repeated with PBS-T and 
once with PBS for 5 min. Signals were detected using chemiluminescent HRP substrate 
(Millipore) and exposed to X-ray film. To reprobe the membrane with a different 
antibody, stripping was done after washing with 1X PBS twice for 10 min each. 
Specifically, the blot was incubated with stripping buffer (62.5 mM Tris-HCl pH 6.7, 2% 
SDS, 100 mM β-mercaptoethanol) for 30 min at 50°C and washed thrice with 1X PBS. 
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The blot was blocked again in 5% milk overnight before probing it with the next primary 
antibody. 
 
7.13. Monolayer lysis assay  
To monitor parasite growth in glutamine-supplemented media (see section above), 
monolayer lysis was done as described earlier (Shen and Sibley, 2014). Essentially, 
parasite and HFF monolayer were starved in absence of glucose (of L-glutamine as 
control) for 2 hrs before inoculation as described in the above section. Subsequently, 
confluent HFF cells in 96 well plates were inoculated with parasite dilutions in triplicate 
and allowed to grow for 48 hrs under the indicated conditions. Lysis was assessed by 
crystal violet staining and measuring absorbance at 570 nm using Molecular Dynamics 
M5 plate reader by well scanning.   
 
7.14. ATP measurement 
ATP concentration was determined using the CellTiter-Glo Luminescent Cell Viability 
Assay (Promega; Madison, WI) according to manufacturer’s protocol. In general, 
intracellular parasites grown 60 hrs ± ATc, were filtered, centrifuged and resuspended in 
dye free DMEM supplemented with 1% Fetal Bovine serum, 10 U/ml penicillin, 100 
µg/ml streptomycin and 1mM glutamine medium to 107 parasites/ml. 100 µL parasites 
were added to a 96 well plate and equilibrated at room temperature for 30 min An equal 
volume of CellTiter-Glo reagent was added and the plate was shaken for 5 min to allow 
cell lysis. An M5 plate reader (Molecular Dynamics) was used to record luminescence at 
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500 ms integration speed after 10 min. ATP (disodium salt) was used to generate the 
standard curve.  
 
7.15. GAPDH activity assay 
GAPDH activity in parasite lines grown ± ATc (60 hrs) was measured by the colorimetric 
based assay from ScienceCell Research Laboratories as described in the manufacturer’s 
protocol. Basically, GAPDH activity was measured in parasite lysate by assaying the rate 
of NADH oxidation, which is proportional to the reduction in absorbance at 340 nm over 
time (ΔA340 nm/min). In the presence of 3- phosphoglyceric acid (3-PGA), adenosine 5’-
triphosphate (ATP) and GAPDH, the oxidation of β-NADH to β-NAD occurs. 
Specifically, parasite lysate was prepared by syringe-lysis, filtration through a 3 µm 
polycarbonate filter and centrifugation at 1000g for 15 min. The parasite pellet was 
washed twice with PBS. The parasite pellet was treated with ice-cold lysis buffer for 20 
min at 4°C with gentle agitation. The lysate was centrifuged at 14000 rpm for 5 min and 
supernatant was carefully collected and stored at -80°C until detection of activity. Cell 
assay buffer was prepared and initial absorbance was measured using a Molecular 
Dynamics M5 plate reader. After addition of cell lysate supernatant or GAPDH standard 
the absorbance was measured over time. The rate of decrease in absorbance was 
calculated to determine the standard curve and derive the GAPDH activity in the sample, 
Parasites carrying different GAPDH1 alleles were diluted to the point wherein the 
activity measured within the dynamic range of the assay and activity was normalized to 
internal control of the parental and wild type complemented line present in each assay. 
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Additionally, another kit designed for crude serum and tissue samples (GAPDH Assay kit 
Cat # E-101) was tested before we used the above-described colorimetric assay for cell 
lysates. The absorption was measured at 492 nm due to the reduction in NADH was 
measured by the coupled reaction with the tetrazolium salt. The sensitivity of the assay 
for the parasite lysate was low and did not detect the range of activity for different 
GAPDH mutants in the parasite. 
 
7.16. Fractionation assay 
 7.16.1. Differential centrifugation: Fractionation by differential centrifugation was 
adapted from a previously described method (Taha et al., 2014). To fractionate the 
membrane bound vs. cytosolic proteins, parasite pellet (1x108) was cooled in liquid 
nitrogen for 5 min and then thawed at 37°C before resuspending in hypotonic buffer (10 
mM Tris pH 7.8 and 5 mM NaCl). The resuspended pellet was mechanically lysed using 
40 strokes of a douncer and centrifuged at low speed (1000g) for 15 min at room 
temperature in Eppendorf centrifuge 5417C using rotor FA45-30-11. The supernatant 
was carefully separated (Lo Sp-S1) and the pellet was resuspended in equal volume of 
resuspension buffer (100 mM Tris pH 7.8 and 150 mM NaCl). A protease inhibitor 
cocktail (Sigma) was added in a 1:100 ratio and loaded as Lo Sp-P1. The resuspended 
pellet was equally divided in 5 parts and either centrifuged at 4°C at 100,000g for 60 min 
in Beckman optima TLX ultracentrifuge (Hi Sp-P) or extracted by detergent as described 
below. Equivalent volume of the low speed supernatant was also centrifuged at high 
speed for 60 min (Hi Sp-S).  
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 7.16.2. Detergent extraction: Detergent extractions were performed essentially as 
described previously (Gubbels et al., 2006). The low spin pellet fraction was treated with 
1% SDS, 1% TX-100, 0.5% NP-40 or no detergent as control in resuspension buffer. 
SDS extraction was performed for 10 min at 98°C and then the samples were spun at 
room temperature for 20 min at 13,000 rpm. All other extractions were performed on ice 
for 45 min and then spun at 4°C for 20 min at 13,000 rpm. Supernatants were removed as 
the soluble fraction and the pellets were resuspended in a volume of resuspension buffer 
equivalent to the supernatant. Following extractions, the pellet and supernatant fractions 
were separated and western blot was performed as described above.   
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Table 7.1. PCR Primers and protospacers All protospacers used in the study are 
phosphorylated at 5’ end. In the oligonucleotides, the restriction enzyme sites are 
italicized and underlined, Att-recombination sites are underlined and mutagenesis sites 
are represented in bold font. ____________________________________________________________________________________________________________________	  
#     Protospacers name    Sequence ____________________________________________________________________________________________________________________	  
1. 5-IMC12dKO-s      /5Phos/AAGTT GTACTTCGCTCTGTGAATTTGG       
2. 5-IMC12dKO-as      /5Phos/AAAAC CAAATTCACAGAGCGAAGTACA     
3. 3-IMC12dKO-s      /5Phos/AAGTT GCGTCGACTCCATGCCCCAGTG        
4. 3-IMC12dKO-as  /5Phos/AAAAC ACTGGGGCATGGAGTCGACGCA       
5. 5-IMC14dKO-s  /5Phos/AAGTT GtaccaatagtggacacgATGG       
6. 5-IMC14dKO-as  /5Phos/AAAAC CATcgtgtccactattggtaCA     
7. 3-IMC14dKO-s  /5Phos/AAGTT GAGTCCGCAGTCTCGTGAATTG        
8. 3-IMC14dKO-as  /5Phos/AAAAC AATTCACGAGACTGCGGACTCA        
______________________________________________________________________________________ 
 
#        IMCs Primer name   Sequence 
______________________________________________________________________________________ 
 
1. 5’IMC7-F-B1       GGGGACAAGTTTGTACAAAAAAGCAGGCTGCGTCCAGTTCACAGCTCCCAACAC 
2. 5’IMC7-F-B4       GGGGACAACTTTGTATAGAAAAGTTGGGTGGCACTGGCAGAACGGCGTCTG 
3. 3’IMC7-F-B3       GGGGACAACTTTGTATAATAAAGTTGcgATGGAGTTCACTGCTGACAACGTAC 
4. 3’IMC7-R-B2       GGGGACCACTTTGTACAAGAAAGCTGGGTACGCGATCGTGAATGGTCGGAC 
5. 5’IMC7ver-F       GAACGACCAGACATCCGATGTTCT 
6. 3’IMC7ver-R       CGTGTACACCAAGTCCAAGGGC 
7. 5’U6_sequence-F        ctcgtagagaacaagcactcg 
8. 5’IMC12-DHFR-F      cactcctttatttgggaaaccaccttgtctttgctCACGAAACCTTGCATTCAAAC        
9. 3’IMC12-DHFR-R      ctggtccacacttcccctctacggaaaagcggttcATCCTGCAAGTGCATAGAAGG  
10. 5’IMC12ver-F   cagGTTTAAACCACCAACAAATCCAACAACTTCCG        
11. 3’IMC12ver-R  GGGGACCACTTTGTACAAGAAAGCTGGGTAGCTGTCTGATTCGGTTGGACTTC  
12. 3’DHFR-CXR   ACTGCGAACAGCAGCAAGATCG 
13. 5’DHFR-ver-F   CACACAGTCTCACCTCGCCT   
14. 3’IMC12ver-N-R   cgtactacagcgtgttcacg   
15. IMC12dko-int-ver-F  GGGGACAAGTTTGTACAAAAAAGCAGGCTGCCAGCATGCTGGCGGTACCCAAC  
16. IMC12dko-int-ver-R  GGGGACAACTTTGTATAGAAAAGTTGGGTGCGCACAACCGGTGAACAGAATAC 
17. IMC12-S249A-S250A-R  CTCGCTCACGCGAGAGAAAACCCGCGGTGCCGCGGCGAGAGAGCCCACTGCCGCCTC 
18. IMC12-S249E-S250E-R  CTCGCTCACGCGAGAGAAAACCCGCGGCTCCTCGGCGAGAGAGCCCACTGCCGCCTC 
19. 5’IMC14-DHFR-F   cttgtgtttcgtgtggaccggaaggaaatcCACGAAACCTTGCATTCAAACC 
20. 3’IMC14-DHFR-R   catacggcatctgtatttgaacatactcgcctgcATCCTGCAAGTGCATAGAAGG          
21. 5’IMC14ver-F   cagGTTTAAACTCGCATGCTGAGGAACCAACC   
22. 3’IMC14ver-R   cgccgctatattaagccttgc   
23. IMC14dko-int-ver-F  gtgactgggcgatgagcg    24. IMC14dko-int-ver-R  CGGGACATCACGGTACTTATACTC 	  ____________________________________________________________________________________________________________________	  
#	  	  	  	  	  GAPDH1 Primer name    Sequence ____________________________________________________________________________________________________________________	  
1.  GAPDH1-F-Avr          cagCCTAGGATGGTGTGCAAGCTGGG 
2.  GAPDH1-R-RV          cagGATATCTTACGCGCCGTCCTGGACG 
3.  GAPDH1F-BglII        cagAGATCTaaaATGGTGTGCAAGCTGGG 
4.  GAPDH1-R-AvrII       cagCCTAGGCGCGCCGTCCTGGACGG 
5.  GAPDH1-F-B1      GGGGACAAGTTTGTACAAAAAAGCAGGCTgcGCGATACAACGGATCACTGTCG  
6.  GAPDH1-R-B4      GGGGACAACTTTGTATAGAAAAGTTGGGTGGTCGTGTAACTGCGTCCCGC  
7.  GAPDH1-F-B3      GGGGACAACTTTGTATAATAAAGTTGaaATGGTGTGCAAGCTGGGTATTAACG  
8.  GAPDH1-R-B2          GGGGACCACTTTGTACAAGAAAGCTGGGTAGTAGTGGCCGTGGACCGAG  
9.  5-GAPDH1-ver-F       GTACCGTGAACGGTAGACCTC 
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10. 5-DHFR-CXR           ACTGCGAACAGCAGCAAGATCG 
11. 3-DHFR-CVI-F1        GTGCTGGACTGTTGCTGTCTGC  
12. 3-GAPDH1-ver-R       CGTTGGTCAAGTGAGCCTGAG 
13. GAPDH1-pro-ver       GAGGTGGGAGTTGGTATAGTCAATC 
14. GAPDH1-C152G-F       GATGTCATTGTGTCGAACGCCTCTGGAACGACCAACTGCTTGGCTCCTCTCGCC        
15. GAPDH1-C152G-R       GGCGAGAGGAGCCAAGCAGTTGGTCGTGCAAGAGGCGTTCGACACAATGACATC 
16. GAPDH1-S50A-R        GGGGTAGTGGCCGTGGACGGCGTCGTATCTCAGAAGGTACACCATGTAGTC 
      17. GAPDH1-S203A-R       GGCAGGGATGATGTTGACGCCTGCGGCCCGGCCAGCGCGCCAATCTTTGCC 
18. GAPDH1-S50E-R        GGGGTAGTGGCCGTGGACCTCGTCGTATCTCAGAAGGTACACCATGTAGTC 
19. GAPDH1-S203E-R       GGCAGGGATGATGTTGACGCCTGCCTCCCGGCCAGCGCGCCAATCTTTGCC 
20. GAPDH1-Y41F-R        GTATCTCAGAAGGTACACCATGAAGTCCAGGGACATGAACGGGTC 
21. GAPDH1-Y41E-R   GTATCTCAGAAGGTACACCATCTCGTCCAGGGACATGAACGGGTC 
22. GAPDH1-K162R-R         GCCGAACTTATCGTGGACAATTCTGGCGAGAGGAGCCAAGCAGTT 
23. GAPDH1-K162Q-R         GCCGAACTTATCGTGGACAATCTGGGCGAGAGGAGCCAAGCAGTT 
24. GAPDH1-C3S-F   ATGGTGAGCAAGCTGGGTATTAACGGTTTTGGC 
25. GAPDH1-C249S-R  CTTCGCGGGCTTGGCCAGCTTGCTGGTCAGATCAACCACAGACAC 
______________________________________________________________________ 	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APPENDIX A: Functional characterization of IMC15, the first known cytoskeletal 
component of Toxoplasma gondii daughter buds 
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A.1. Introduction 
The unique division of the intracellular apicomplexan parasite Toxoplasma gondii 
involves the assembly of two daughter cells within the mother (Sheffield and Melton, 
1968). This process of endodyogeny or internal budding unfolds with the initiation of a 
new inner membrane complex (IMC), a series of flattened, cortical vesicles or alveoli 
(Hu et al., 2002). On the cytoplasmic side of the IMC lies a network of 8-10 nm 
intermediate filament-like proteins called alveolar IMC proteins (Mann and Beckers, 
2001). These proteins contain a repeat of valine and proline rich domains called alveolin 
motifs conserved throughout the super-phylum alveolates that includes ciliates, 
dinoflagellates and apicomplexans (Gould et al., 2008). Toxoplasma has a family of 14 
alveolin domain IMC proteins all containing alveolin repeat motifs. Their assembly 
dynamics resolved previously unappreciated discrete spatio-temporal events in the 
division process of this parasite (Anderson-White et al., 2011). Specifically, IMC15 was 
identified as the earliest cytoskeleton marker of budding. IMC15 is first recruited to the 
duplicated centrosomes, which are the staging hub for daughter assembly (Anderson-
White et al., 2011) and subsequently translocates to the newly assembling buds (Gubbels 
et al., 2006). Hence, we propose that IMC15 is a scaffolding protein and recruits 
cytoskeletal proteins to complete daughter cell budding.   
 Division in Toxoplasma unfolds with the duplication of the Golgi apparatus and 
centrosome followed by the assembly of the cortical cytoskeleton on the duplicated 
centrosomes. The new cytoskeleton forms the scaffold for anchoring new organelles in 
the daughter buds within the mother (Nishi et al., 2008). Previous studies have 
established a timeline of early budding (Anderson-White et al., 2012). In addition to 
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IMC15, Rab11B, an alveolate specific subfamily member of Rab11-GTPases, localizes 
early to the growing IMC of the replicating parasites (Agop-Nersesian et al., 2010). 
Rab11B is required for transporting the vesicles from the Golgi to the IMC during 
daughter cell assembly and biogenesis of the IMC (Agop-Nersesian et al., 2010). 
Additionally, actin-like protein1 (ALP1) is localized to the apical end of dividing 
daughter cells and is required for the daughter IMC formation (Gordon et al., 2008). In 
the early budding stages, a family of ISP proteins organized along the IMC sub-
compartments are recruited to the bud (Beck et al., 2010). Moreover, the glideosome-
associated proteins GAP40 and GAP50 also appear in the early stage of budding and are 
required for completing the assembly of the new daughters and maintaining their stability 
(Harding et al., 2016). Overall, the early appearance of IMC15 in daughter cell formation 
suggests it could function as an essential scaffolding protein required to recruit the 
subsequent building blocks, which we pursued here by disrupting IMC15 expression.  
 The exact mechanism of the budding process has not been deciphered and 
therefore we pursued the functional characterization of IMC15, the first cytoskeletal 
component of budding. Previous attempts to directly knockout this gene in the parasite 
were unsuccessful suggesting that it may be essential (Anderson-White and Gubbels, 
2011). Several additional strategies to create a conditional knockdown of IMC15 were 
equally unsuccessful due to background expression near the low natural expression level 
of this gene (Anderson-White and Gubbels, 2011). Here we have used new powerful 
genome editing technology to overcome the previous problems since it offers robust 
experimental paths to test and characterize any gene in the parasite. In this study, we 
were able to generate an IMC15 direct knockout (dKO) line through CRISPR/Cas9 
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genome editing (Sidik et al., 2014), (Shen et al., 2014).  We explored the role of this gene 
in the lytic cycle of the parasite. We discover that although loss of IMC15 is not critical 
for the lytic cycle of the parasite, it is critical for a correct execution of endodyogeny as 
we observe an increased frequency of more than two daughters per division round. This 
suggests IMC15 could be a scaffolding protein serving as a checkpoint or regulator of the 
endodyogeny process.  
 
  
153	  	  
A.2. Results 
A.2.1. IMC15 is not essential for completing the lytic cycle of Toxoplasma 
To probe the function of IMC15 in the initiation of daughter cell budding we adopted a 
direct knockout strategy using CRISPR/Cas9 genome editing (Sidik et al., 2014). 
CRISPR/Cas9 was used to create a targeted double stranded break at the gene locus 
which was repaired using a template with homologous flanks to replace the IMC15 
coding sequence generated by PCR and encoding the drug selectable marker DHFR-TS 
(Figure A.1. a). Successful replacement of the locus and absence of reintegration of the 
IMC15 coding sequence elsewhere in the genome was validated by diagnostic PCR 
reactions (Fig A.1b). The ability to generate an IMC15 dKO clonal line is an indication, 
in itself, that IMC15 is not essential for the lytic cycle of the parasite. However, to 
measure subtle effects on replicative efficiency we performed a plaque assay on the dKO 
line and the WT parent line, which measure integrated growth over a period of nine days 
(Figure A.2. a). Indeed we observed plaques of comparable numbers supporting that 
IMC15 is not essential. However, IMC15 dKO plaques appeared slightly larger, but upon 
careful quantification this effect was not statistically significant (Figure A.2. b).   
 
A.2.2. IMC15 is not required for initiation of daughter cells 
Based on previously published data, we hypothesized that IMC15 acts as a cue for 
initiation of budding in the parasite (Anderson-White et al., 2011). We assessed the effect 
of loss of IMC15 on the early budding process by IFA using the IMC3 marker for 
daughter development (Anderson-White et al., 2011). We observed no defect in daughter 
cell formation as indicated by incorporation of IMC3 in the dKO line (Fig A.3. a). Our 
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data suggest that IMC15 is not an essential scaffolding protein for incorporation of other 
cytoskeletal or membrane components in the budding daughter.  
 
A.2.3. Loss of IMC15 results in endopolygeny 
The increased plaque size upon loss of IMC15 prompted us to evaluate this intriguing 
phenotype by IFA using a centrosome (centrin) and daughter scaffold (IMC3) marker for 
daughter development (Szatanek et al., 2012). As a control we used the WT line and as 
expected it showed normal internal budding with duplicated centrosomes associated with 
two budding daughters within the mother (Figure A.3. b). In our dKO line, on the other 
hand, we frequently observed four centrosomes and four daughters in one mother (Figure 
A.3. a). At a lower frequency, three daughters and four centrosomes per mother were 
observed (lower panel Figure A.3. a). The multiple centrosomes each give rise to new 
daughters thereby generating more than two offspring per division round (i.e. 
endopolygeny). Although multiple (>2) daughters form at a low 1-2% frequency in 
normal parasites (Hu et al., 2004), quantification of this phenotype in parasites without 
IMC15 revealed the incidence increased to 25% ( Figure A.3. c). Taken together, our data 
suggest that IMC15 is critical in regulating or controlling the number of daughter buds 
per division round. 
.   
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A.3. Discussion 
IMC15, the earliest known cytoskeletal component of daughter cell budding in 
Toxoplasma, is surprisingly not essential for the lytic cycle of the parasite (Figure A.2. a). 
Multiple attempts at depleting IMC15 protein in the parasite by various techniques were 
unsuccessful in the past, which suggested a critical role in parasite viability. But with 
novel CRISPR/Cas9 mediated high efficiency genome editing we were able to create an 
IMC15 dKO line. These results appear contradictory and it is feasible that efficiency of 
CRISPR permits selection for compensatory mechanisms counteracting the loss of 
IMC15. At this point we are unable to assess this possibility directly. However, we do see 
a disregulatory effect on the endodyogeny due to ablation of IMC15 as we observe an 
increase in multiple daughters per division round (Figure A.3. c). 
 To understand this phenotype we have to consider the controls underlying cell 
division cycle progression. The division of the parasite starts with the duplication of 
Golgi followed by the centrosome duplication. The Toxoplasma centrosome is a 
functionally bipartite structure (Suvorova et al., 2015). The inner core is thought to 
regulate the mitotic cycle in the nucleus, whereas the outer core functions in daughter cell 
assembly. By separately controlling the inner and outer cores, the parasite is able to 
successfully uncouple mitosis from daughter budding, thereby enabling endopolygeny. 
The formation of multiple daughters within a mother is reminiscent of another division 
mode of Toxoplasma i.e. endopolygeny that occurs in the definitive hosts (cats) or in 
other apicomplexans like Sarcocystis (Speer and Dubey, 1999). Furthermore, multiple 
daughters naturally form in tachyzoite tissue culture at a low frequency, under mild 
experimental stimuli (Hu et al., 2004). Since IMC15 is assembled on the duplicated 
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centrosome our initial hypothesis was that it served as a scaffolding protein recruiting 
additional cytoskeleton proteins. However, our data indicate that this is not the case since 
additional IMC proteins are added to the forming daughters and the budding process is 
completed (Figure A.3. a). The unexpected observation of multiple daughters in absence 
of IMC15 suggests a different role, most likely in timely activation or control of the outer 
core centrosome cycle. 
 Similar multi-daughter phenotypes have been observed with other mutants. E.g., 
in the absence of the GTPase activity of Rab6 (Stedman et al., 2003). Rab6 regulates the 
retrograde transport of proteins between post Golgi secretory granules to the parasite’s 
Golgi apparatus, and functional disruption shifts cytokinesis toward endopolygeny in 
24% of the parasites (Stedman et al., 2003), a percentage closely reflecting our 
observations upon loss of IMC15. In addition, TgNCR1, a protein containing a canonical 
sterol-sensing domain in the parasite related to the Niemann-Pick, type C1-related protein 
(NPC1) with significant identity to Human NPC1, is required for stimulation of lipid 
storage, membrane biosynthesis and parasite division. The deletion of TgNCR1 shows 
endopolygeny at an incidence of about 75% due to deregulation of trafficking of the 
lipids necessary for daughter formation (Lige et al., 2011). Furthermore, deletion of IMC 
sub-compartment protein ISP2 also leads to a high frequency (60%) of multiple daughters 
per mother along with loss in fitness (Beck et al., 2010). Although the function of ISP2 is 
unknown, both Rab6 and NPC1 are involved in membrane trafficking or biogenesis. It 
therefore appears that timely availability of membrane is critical for the daughter bud 
initiation function of the outer centrosome core. Since IMC15 is predicted to be 
palmitoylated and the IMC meshwork is anchored in the alveolar membranes, a feasible 
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model is that IMC15 assists in recruiting, anchoring or fusing vesicles trafficking from 
the Golgi to start assembly of the new daughter. Thus, if the efficiency of this process is 
reduced by deleting of IMC15 it can easily be envisioned that the outer core will not 
properly execute its job and subsequently the parasite will forgo daughter development 
eventually leading to another mitotic round producing a total of four centrosomes. This 
would assign in essence an assistant scaffolding function to IMC15, though not an 
essential one. In conclusion, this part of my thesis sheds significant light on 
understanding the role of IMC15 in the initiation of daughter budding. Additionally, 
similar expression level of IMC15 in all zoite forms (Hehl et al., 2015) identifies it as a 
potential regulator of daughter formation in the parasite.  
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Figure legend A.1. Generation of IMC15 dKO and validation by PCR 
 
(a) IMC15 dKO strategy by homologous recombination using CRISPR/Cas9 based 
technology. Protospacers targeting gDNA of IMC15 after the start and stop codon were 
used to direct the DNA cleavage by Cas9. Using 35 bp homologous regions (red) 
flanking the DHFR selectable marker the IMC15 coding sequence was replaced. 
Recombination was performed in the Δku80 background (WT). Pyrimethamine resistant 
parasites were selected and cloned by limiting dilution. (b) Diagnostic PCR reaction to 
verify the IMC15 dKO line genotype. As expected, pair I PCR is present both in the WT 
and dKO line, but generates a different sized band indicating integration at the correct 
locus. Pair II additionally validates correct genomic integration. No PCR product in Pair 
III for the dKO line shows that the IMC15 gDNA is not randomly reintegrated else where 
in the genome.  
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Figure A.1. Generation of IMC15 dKO and validation by PCR 
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Figure legend A.2. IMC15 is not essential for the lytic cycle 
 
(a) Representative image of plaque assays of WT and IMC15 dKO line after nine days 
incubation.  (b) Quantification of plaque size of both the lines by measuring their plaque 
area of 30 plaques in each experiment. N=3 ± s.e.m. The data is not statistically 
significant using the unpaired t-test.  
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Figure A.2. IMC15 is not essential for the lytic cycle 
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Figure legend A.3. Loss of IMC15 causes multi-daughter phenotype  
 
IFA images of  (a) IMC15dKO (dKO) and (b) Wild type (WT) parasite lines using 
α−IMC3 and α−h-Centrin antibodies after methanol fixation. The top panel shows the 
vacuoles with initiating and early daughter buds, middle panel has budding daughters in 
mid-phase and in the bottom panel the daughters are late phase of maturation. (c) Graph 
showing the quantification of the multiple-daughter phenotype in the marked lines by 
counting 200 vacuoles in each experiment.  N=3 ± s.e.m. The statistical significance was 
calculated using unpaired two-tailed t-test.  
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Figure A.3. Loss of IMC15 causes multi-daughter phenotype 
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A.4. Material and Methods 
A.4.1. Parasites  
RH strain parasites and their transgenic derivatives were cultured and maintained as 
described in Chapter 6 (Material and Methods). Specifically, the double stranded breaks 
generated by Cas9 must be repaired by Homologous Recombination (HR) (Fox et al., 
2009; Huynh and Carruthers, 2009), hence KU80, a Non-Homologous End-Joining 
(NHEJ) facilitating DNA-binding protein, lacking parasite line (Δku80) was used to 
facilitate this.  
 
A.4.2. Plasmids 
All primer sequences used in this study are listed in Table A.1. IMC15 dKO line was 
generated using the CRISPR/Cas9 system. A 20 base pair unique protospacer or guide 
sequence beside the protospacer-adjacent motif (PAM) was designed using the program 
ProtoMatchv2.0 (script by Sebastian Lourido:	  http://louridolab.wi.mit.edu/) at the 5’ and 
3’ end of the IMC15 gDNA.  The annealed phosphorylated oligonucleotides 
corresponding to these unique protospacer were then cloned into the pU6 plasmid (kindly 
donated by Sebastian Lourido Lab, Whitehead Institute) between the BsaI sites to 
generate the pU6-IMC15 plasmid. Sanger sequencing using the U6_sequence forward 
primer was used to sequence the final plasmids and verify the protospacers. DHFR locus 
was amplified from the DHFR-teto7SAG4 vector (kind gift from Wassim Daher 
(Morlon-Guyot et al., 2014)) using the primers (#2 and #3) with homologous flanks to 
IMC15 mentioned in Table A.1. 20 µg each plasmid was transfected into the Δku80 
parasite line alongwith 40 µg PCR product of the DHFR resistant marker for drug 
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selection. 1 µg/ml of pyrimithine was added the following day to select the resistant 
parasites. 
 
A.4.3. Verification of the knockout line  
Within a week of transfection and drug selection using pyrimethamine, stable lines 
resistant to the drug were obtained. The gDNA was isolated and purified from the 
parasite using the Zymo gDNA isolation kit and diagnostic PCR reactions were done. 
The sets of primers used to verify the genotype are listed in Table A.1. After obtaining 
the parasite lines with successful integration of the DHFR cassette within the IMC15 
locus, cloning by limiting dilution was done in a 384 well plate. A clone was used for all 
subsequent assays. 
 
A.4.4. Plaque assay 
Plaque assay was done as described in detail in the Chapter 6. Both WT and dKO line 
were incubated for 9 days before fixation and staining. The stained plaque assay plates 
were scanned and plaque size was measured in Fiji in three independent experiments. 
 
A.4.5. Immunofluorescence 
IFAs were performed as previously described in Chapter 6, 18 hpi (hours post infection). 
The following primary antibody was used rat α-IMC3 (1:2000) to mark the daughter 
buds and mother IMCs and rabbit α-human centrin (1:1000) to label the centrosomes. 
Alexa fluorophores (1:400) A594 conjugated to a goat-α−rat secondary antibody and 
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A488 conjugated to a goat-α−rabbit secondary antibody were used. Nuclear material was 
co-stained using DAPI (2 µg/ml). 
 
A.4.6. Fluorescence microscopy and phenotype quantification 
Wide field fluorescence microscope was used as previously described in Chapter 6. After 
IFA for quantification of the phenotype, more than 100 random vacuoles in budding stage 
were counted for both IMC15 dKO line and Δku80 parental parasite line. Statistical 
significance was calculated using two-tailed unpaired t-test on PRISM graphpad 
software.  
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Table A.1.  Appendix protospacers and primer sequences 
 
_____________________________________________________________________________________  
# Protospacers name  Sequence ____________________________________________________________________________________________________________________	  
1. 5-IMC15dKO-s   /5Phos/AAGTTGAGAGAATTTTTCTAAAATGG 
2. 5-IMC15dKO-as   /5Phos/AAAACCATTTTAGAAAAATTCTCTCA  
3. 3-IMC15dKO-s   /5Phos/AAGTTGCACAGTGTTGCCAGTCACCGG 
4. 3-IMC15dKO-as   /5Phos/AAAACCGGTGACTGGCAACACTGTGCA 
 
 
 #  Primer name   Sequence 
 
 
1. U6_sequence-F   ctcgtagagaacaagcactcg 
2. 5’IMC15-DHFR-F  gaaaggacacgctttgcacacaccggcgtcacagcCACGAAACCTTGCATTCAAACC 
3. 3’IMC15-DHFR-R  cgtttcctagacaatccgtctcctcaaggaggagcATCCTGCAAGTGCATAGAAGG 
4. 5’IMC15ver-F  GTGTACTGGTGTTCGAGGCTATG 
5. 5’DHFR-CXR  ACTGCGAACAGCAGCAAGATCG 
6. 3’IMC15ver-R  CAAACCAAATGATGCGGTCCCTG 
7. IMC15dko-int-ver-F cagaactgcaagagacaccg  
8. IMC15dko-int-ver-R  ctgcagtgcaagaattccgc 
_______________________________________________________________________ 
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